Page last updated: 2024-12-10

rosmarinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

rosemarinic acid: a dimer of caffeic acid isolated from rosemary [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

rosmarinate : The conjugate base of rosmarinic acid; major species at pH 7.3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

rosmarinic acid: RN given refers to parent cpd; promote OT project [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(R)-rosmarinic acid : A stereoisomer of rosmarinic acid having (R)-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

rosmarinic acid : The 1-carboxy-2-(2,4-dihydroxyphenyl)ethyl ester of trans-caffeic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5315615
CHEMBL ID66966
CHEBI ID17226
SCHEMBL ID19348
MeSH IDM0122724
PubMed CID5281792
CHEMBL ID324842
CHEBI ID50371
CHEBI ID92370
SCHEMBL ID1650675
SCHEMBL ID2028694
MeSH IDM0122724

Synonyms (147)

Synonym
nsc-687846
CHEBI:17226 ,
alpha-(((3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy- benzenepropanoic acid
3-(3,4-dihydroxyphenyl)-2-[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]propanoic acid
537-15-5
BSPBIO_003595
MLS001097740
smr000578091
rosemarinic acid
rosmarinate
3-(3,4-dihydroxyphenyl)-2-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-propanoic acid
3-(3,4-dihydroxyphenyl)-2-((3-(3,4-dihydroxyphenyl)acryloyl)oxy)propanoic acid
nsc687846
NCGC00094959-03
NCGC00094959-02
NCGC00094959-01
SPECTRUM1502094
NCGC00094959-04
HMS1921J08
bdbm50059986
cid_5315615
chembl66966 ,
2-[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]-3-(3,4-dihydroxyphenyl)propano ic acid
AM84697
3-(3,4-dihydroxyphenyl)-2-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}propanoic acid
CCG-214251
SCHEMBL19348
AKOS024283449
DOUMFZQKYFQNTF-ZZXKWVIFSA-N
(r)-.alpha.-[[3-(3,4-dihydroxyphenyl)-1-oxo-2e-propenyl]oxy]-3,4-dihydroxybenzenepropanoic acid
CS-6460
rosmarinic acid (racemate)
HY-N2336
sr-01000597653
SR-01000597653-1
SR-01000597653-4
rosmarinsaure
Q7762
BRD-A03397678-001-06-2
benzenepropanoic acid,a-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-3,4-dihydroxy-
EN300-718656
179462-74-9
HMS3266D13
r-(+)-2-(3,4-dihydroxycinnamoyloxy)-3-(3,4-dihydroxyphenyl)propionic acid
cinnamic acid, 3,4-dihydroxy-, 2-ester with 3-(3,4-dihydroxyphenyl)lactic acid
3,4-dihydroxycinnamic acid 2-ester with 3-(3,4-dihydroxyphenyl)lactic acid
benzenepropanoic acid, alpha-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-, (r-(e))-
ACON1_001068
(2r)-o-caffeoyl-3-(3,4-dihydroxyphenyl)lactic acid
CHEBI:50371 ,
(r)-rosmarinic acid
(2r)-3-(3,4-dihydroxyphenyl)-2-[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]propanoic acid
benzenepropanoic acid, .alpha.-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-, (r-(e))-
benzenepropanoic acid, .alpha.-[[(2e)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-3,4-dihydroxy-, (.alpha.r)-
(2r)-3-(3,4-dihydroxyphenyl)-2-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-propanoic acid
rosemary acid
MEGXP0_000163
labiatic acid
rosmarinic acid
C01850
benzenepropanoic acid, alpha-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-
rosmarinic acid, 96%
MLS000697677
rosmarimic acid
smr000445579
20283-92-5
NCGC00169708-01
93B6A3BF-927D-4C59-8A49-29BDBC87C194
rosmarinic acid, 2
cid_5281792
bdbm50133496
CHEMBL324842 ,
BMSE000648
(r)-o-(3,4-dihydroxycinnamoyl)-3-(3,4- dihydroxyphenyl)lactic acid
(2r)-3-(3,4-dihydroxyphenyl)-2-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxypropanoic acid
(2r)-3-(3,4-dihydroxyphenyl)-2-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}propanoic acid
hsdb 7688
(r)-o-(3,4-dihydroxycinnamoyl)-3-(3,4-dihydroxyphenyl)lactic acid
A814378
HMS2227A13
S3612
labiatenic acid
ccris 9361
rm 21a
trans-rosmarinic acid
mqe6xg29yi ,
alpha-(((3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxybenzenepropanoic acid
rosemaric acid
unii-mqe6xg29yi
nplc 0542
AKOS015892734
rosmarinic acid [inci]
rosmarinic acid (constituent of holy basil leaf) [dsc]
rosmarinic acid [hsdb]
benzenepropanoic acid, .alpha.-(((2e)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl)oxy)-3,4-dihydroxy-, (.alpha.r)-
rosmarinic acid (constituent of rosemary) [dsc]
rm-21a
oristract roa
rosmarinic acid [usp-rs]
nplc-0542
rosmarinic acid [mi]
162281-84-7
benzenepropanoic acid, .alpha.-(((2e)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-, (.alpha.r)-
CCG-208268
CCG-207919
SCHEMBL1650675
rosmarinicacid
SCHEMBL2028694
AC-33965
Q-100246
rosmarinic-acid
[r-(+)]-?-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-3,4-dihydroxybenzenepropanoic acid
(r,e)-3-(3,4-dihydroxyphenyl)-2-((3-(3,4-dihydroxyphenyl)acryloyl)oxy)propanoic acid
HY-N0529
HMS3649C22
mfcd00017740
rosmarinic acid, primary pharmaceutical reference standard
CHEBI:92370
rosmarinic acid, united states pharmacopeia (usp) reference standard
DOUMFZQKYFQNTF-WUTVXBCWSA-N
rosmarinic acid, >=98% (hplc), from rosemarinus officinalis l.
rosmarinic acid, european pharmacopoeia (ep) reference standard
F0001-0715
(r,e)-3-(3,4-dihydroxyphenyl)-2-(3-(3,4-dihydroxyphenyl)acryloyloxy)propanoic acid
DTXSID20896987 ,
Q50380051
HMS3675K16
AS-35341
sr-01000946599
SR-01000946599-1
rosmarinic acid racemate
HMS3411K16
ZB1872
benzenepropanoic acid,a-[[(2e)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-3,4-dihydroxy-,(ar)-
HMS3885I15
(2r)-3-(3,4-dihydroxyphenyl)-2-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxypropanoicacid
EN300-364852
(2r)-3-(3,4-dihydroxyphenyl)-2-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}propanoic acid
(r,e)-3-(3,4-dihydroxyphenyl)-2-((3-(3,4-dihydroxyphenyl)acryloyl)oxy)propanoicacid
benzenepropanoic acid, alpha-(((2e)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl)oxy)-3,4-dihydroxy-, (alphar)-
benzenepropanoic acid, alpha-(((2e)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-, (alphar)-
dtxcid801326415
rosmarinic acid (constituent of holy basil leaf)
rosmarinic acid (constituent of rosemary)
alpha-(((3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-benzenepropanoic acid
rosmarinic acid (usp-rs)
3-(3,4-dihydroxyphenyl)-2-((2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyloxy)propanoic acid

Research Excerpts

Overview

Rosmarinic acid is an attractive candidate for skin applications because of its antioxidant, anti-inflammatory, and photoprotective functions. Its poor bioavailability hampers its therapeutic outcome.

ExcerptReferenceRelevance
"Rosmarinic acid is an attractive candidate for skin applications because of its antioxidant, anti-inflammatory, and photoprotective functions, however, its poor bioavailability hampers its therapeutic outcome. "( Chitosan - Rosmarinic acid conjugates with antioxidant, anti-inflammatory and photoprotective properties.
Aguilar, MR; Caro-León, J; Espinosa-Cano, E; Huerta-Madroñal, M; Vázquez-Lasa, B, 2021
)
2.45
"Rosmarinic acid (RA) is a polyphenol that occurs in plants of the Lamiaceae family. "( Phenethyl ester of rosmarinic acid attenuates autoimmune responses during type 1 diabetes development in mice.
Diamantis, D; Gajić, D; Jonić, N; Koprivica, I; Pejnović, N; Saksida, T; Stojanović, I; Tzakos, AG, 2022
)
2.49
"Rosmarinic acid is a natural polyphenolic compound that is found in different plant species and used for different medicinal purposes. "( Rosmarinic acid suppresses inflammation, angiogenesis, and improves paclitaxel induced apoptosis in a breast cancer model via NF3 κB-p53-caspase-3 pathways modulation.
Abd-Alhaseeb, MM; Mahmoud, MA; Okda, TM; Omran, GA, 2021
)
3.51
"Rosmarinic acid (RA) is a well-known ester of caffeic acid and 3,4-dihydroxyphenyllactic acid."( Hydroxycinnamoyltransferase and CYP98 in phenolic metabolism in the rosmarinic acid-producing hornwort Anthoceros agrestis.
Bauerbach, E; Ernst, L; Petersen, M; Wohl, J, 2022
)
1.68
"Rosmarinic acid (RA) is a bioactive phenolic compound commonly found in plants of Lamiaceae and Boraginaceae families."( Biomedical features and therapeutic potential of rosmarinic acid.
Asiri, AM; Azum, N; Hassan, MI; Mohammad, T; Noor, S; Raza, A; Rub, MA; Yadav, DK, 2022
)
1.7
"Rosmarinic acid (RA) is a natural polyphenolic compound with antioxidative property. "( Rosmarinic Acid Attenuates Rotenone-Induced Neurotoxicity in SH-SY5Y Parkinson's Disease Cell Model through Abl Inhibition.
Cao, X; Du, W; Gan, J; Han, B; Han, X; He, J; Li, G; Wang, T; Wang, Z; Zhao, Y; Zheng, W, 2022
)
3.61
"Rosmarinic acid is a polyphenolic compound, abundantly present in herbs of the Lamiaceae family. "( Phenethyl ester of rosmarinic acid ameliorates experimental autoimmune encephalomyelitis.
Diamantis, DA; Dimitrijević, M; Djedović, N; Jevtić, B; Lazarević, M; Miljković, Đ; Momčilović, M; Stanisavljević, S; Stegnjaić, G; Tzakos, AG, 2022
)
2.49
"Rosmarinic acid (RA) is a ubiquitous natural polyphenol with powerful antioxidant and anti-inflammatory activities."( Kidney-Targeted Nanoparticles Loaded with the Natural Antioxidant Rosmarinic Acid for Acute Kidney Injury Treatment.
Duan, Q; Li, J; Wei, X; Wu, J; Yang, Q, 2022
)
1.68
"Rosmarinic acid (RA) is a natural compound of phenolic acids that has pharmacological activity for inhibiting Alzheimer's disease, as well as liver protection."( Rosmarinic acid potentiates and detoxifies tacrine in combination for Alzheimer's disease.
Gao, W; Guo, L; Han, X; Huang, L; Ji, H; Li, X; Qiao, O; Wang, J; Wang, W; Yang, M; Zhang, X; Zhang, Y, 2023
)
3.07
"Rosmarinic acid (RA) is a phenolic compound used for therapeutic purposes in many diseases."( Proflactic effects of rosmarinic acid on spinal cord injury in rats.
Deveci, E; Taş, A; Yükselmiş, Ö, 2022
)
1.76
"Rosmarinic acid (RA) is a natural phenolic compound present in culinary herbs of the Boraginaceae, Lamiaceae/Labiatae, and Nepetoideae families. "( Molecular mechanisms of neuroprotective offerings by rosmarinic acid against neurodegenerative and other CNS pathologies.
Abidi, SWF; Ahmad, F; Laksmi Bs, S; Ramamoorthy, S; Rana, SS; Ranjan, V; Ravaria, P; Saha, P; Saxena, P, 2023
)
2.6
"Rosmarinic acid (RA) is a well-known phenolic acid widely present in over 160 species of herbal plants and known to exhibit anti-tumor effects on breast, prostate, and colon cancers in vitro. "( Rosmarinic acid, the active component of Rubi Fructus, induces apoptosis of SGC-7901 and HepG2 cells through mitochondrial pathway and exerts anti-tumor effect.
Chen, C; Li, J; Liu, Y; Qin, L; Shen, Y; Wang, X; Wu, J; Yao, L; Zhang, A; Zhu, L, 2023
)
3.8
"Rosmarinic acid (RA) is a polyphenol holding anti-inflammatory, antioxidant and neuroprotective properties."( Rosmarinic Acid Improves Cognitive Abilities and Glucose Metabolism in Aged C57Bl/6N Mice While Disrupting Lipid Profile in Young Adults in a Sex-Dependent Fashion.
Berry, A; Cirulli, F; Collacchi, B; Di Francesco, A; Giona, L; Musillo, C; Raggi, C; Ristow, M; Siems, K; Zarse, K, 2023
)
3.07
"Rosmarinic acid (RA) is an abundant phytochemical of"( Comprehensive Insights into Biological Roles of Rosmarinic Acid: Implications in Diabetes, Cancer and Neurodegenerative Diseases.
Anwar, S; Azhar, MK; Hasan, GM; Hassan, MI; Islam, A; Parvez, S; Shamsi, A, 2023
)
1.89
"Rosmarinic acid (RA) is a natural polyphenolic compound with a well-documented neuroprotective effect mainly associated with its anti-inflammatory and antioxidant activities. "( Glioprotective Effect of Chitosan-Coated Rosmarinic Acid Nanoemulsions Against Lipopolysaccharide-Induced Inflammation and Oxidative Stress in Rat Astrocyte Primary Cultures.
Azambuja, JH; Barschak, AG; Bassani, VL; Braganhol, E; Dal Prá, M; Endres, M; Fachel, FNS; Henriques, AT; Koester, LS; Teixeira, HF, 2020
)
2.27
"Rosmarinic acid (RA) is a phenolic natural product first discovered in plants of the mint family (Lamiaceae) and is recognized for its wide range of medicinal properties and potential applications in human dietary and medical interventions."( Independent evolution of rosmarinic acid biosynthesis in two sister families under the Lamiids clade of flowering plants.
Carballo, V; Levsh, O; Mitchell, AJ; Pluskal, T; Weng, JK, 2019
)
1.54
"Rosmarinic acid (RA) is a natural flavonoid with many pharmacological activities including anti-inflammatory, anti-oxidative, anti-bacterial, or anti-fibrotic."( Glycosylation of proteins of human skin fibroblasts is changed by rosmarinic acid.
Iwona, R; Katarzyna, S, 2020
)
1.52
"Rosmarinic acid is a common component of Labiatae plants such as shiso (Perilla frutescens Britton var."( Rosmarinic acid in Perilla frutescens and perilla herb analyzed by HPLC.
Deguchi, Y; Ito, M, 2020
)
2.72
"Rosmarinic acid (RA) is a natural polyphenolic compound derived from many common herbal plants. "( The cytotoxic concentration of rosmarinic acid increases MG132-induced cytotoxicity, proteasome inhibition, autophagy, cellular stresses, and apoptosis in HepG2 cells.
Ozgun, E; Ozgun, GS, 2020
)
2.29
"Rosmarinic acid is a bioactive compound with various pharmaceutical effects and applications."( Aqueous enzymatic extraction of rosmarinic acid from Salvia officinalis: optimisation using response surface methodology.
Cheng, HH; Pham, TTT; Su, CH, 2020
)
2.28
"Rosmarinic acid (RA) is a phenolic acid originally isolated from the herb medicine Rosmarinus officinalis. "( Characterization of the metabolites of rosmarinic acid in human liver microsomes using liquid chromatography combined with electrospray ionization tandem mass spectrometry.
Chen, W; Jia, F; Liu, T; Lu, J; Su, J; Sun, H; Wu, X, 2020
)
2.27
"Rosmarinic acid (RA) is an extract that can be obtained from Lamiaceae herbs and the Boraginaceae family. "( Rosmarinic acid protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in zebrafish embryos.
Chen, T; Han, B; Han, Y; He, J; Li, J; Qian, H; Wang, T; Wang, Z; Zhao, Y, 2020
)
3.44
"Rosmarinic acid (RA) is a potential herbal medicine and has received considerable attention due to its strong antioxidant properties. "( The effects of rosmarinic acid on oxidative stress parameters and inflammatory cytokines in lipopolysaccharide-induced peripheral blood mononuclear cells.
Bastin, AR; Doustimotlagh, AH; Ghahremani, H; Sadeghi, A, 2020
)
2.35
"Rosmarinic acid is a polyphenol and is detectable most primarily in many Lamiaceae families, for instance, Rosmarinus officinalis also called rosemary."( Effects of rosmarinic acid on nervous system disorders: an updated review.
Ghasemzadeh Rahbardar, M; Hosseinzadeh, H, 2020
)
1.67
"Rosmarinic acid (RA) is a natural polyphenolic phytochemical compound that has many important biological activities, such as antioxidant, antimutagenic, and antitumor."( The protective effect of rosmarinic acid on myotube formation during myoblast differentiation under heat stress.
Chen, KL; Li, HX; Lin, ZP; Wang, Y, 2020
)
1.58
"Rosmarinic acid (RA) is a water-soluble phenolic compound extracted from Boraginaceae and Lamiaceae. "( Rosmarinic acid exerts an antagonistic effect on nonalcoholic fatty liver disease by regulating the YAP1/TAZ-PPARγ/PGC-1α signaling pathway.
Bao, L; Gao, C; Ji, R; Jin, Y; Luo, C; Peng, J; Sun, H; Zhang, C; Zhu, W, 2021
)
3.51
"Rosmarinic acid is a polyphenol with antioxidant, anti-inflammatory and insulin-sensitizing effects."( Rosmarinic acid inhibits oxLDL-induced inflammasome activation under high-glucose conditions through downregulating the p38-FOXO1-TXNIP pathway.
Jin, H; Kim, HJ; Ko, YS; Nyandwi, JB; Park, SW; Yun, SP, 2020
)
2.72
"Rosmarinic acid (RA) is a natural compound that is gaining wide popularity owing to its broad-spectrum biological activities. "( Evaluation of Binding of Rosmarinic Acid with Human Transferrin and Its Impact on the Protein Structure: Targeting Polyphenolic Acid-Induced Protection of Neurodegenerative Disorders.
Ahmad, F; Alajmi, MF; Anwar, S; Hassan, I; Hussain, A; Islam, A; Mohammad, T; Shahbaaz, M; Shamsi, A, 2020
)
2.3
"Rosmarinic acid is a phenolic compound commonly found in the Lamiaceae (Labiateae) plant species. "( Rosmarinic Acid-Human Pharmacokinetics and Health Benefits.
Božin, B; Gavarić, N; Hitl, M; Kladar, N, 2021
)
3.51
"Rosmarinic acid (RA) is a caffeic acid derivative known for its anti-inflammatory effects."( Rosmarinic acid attenuates obesity and obesity-related inflammation in human adipocytes.
Georgiev, MI; Savova, MS; Tews, D; Vasileva, LV; Wabitsch, M, 2021
)
2.79
"Rosmarinic acid (RA) is a polyphenol that, when administered orally, is metabolised in the small intestine, compromising its beneficial effects."( Anti-Inflammatory Effects of Rosmarinic Acid-Loaded Nanovesicles in Acute Colitis through Modulation of NLRP3 Inflammasome.
Ávila-Román, J; Illanes, M; Marinho, S; Motilva, V; Talero, E, 2021
)
1.63
"Rosmarinic acid (RA) is a natural, polyphenolic compound with pharmacological activities, including anti-cancer."( Anti-cancer effect of combined action of anti-MUC1 and rosmarinic acid in AGS gastric cancer cells.
Bielawska, A; Radziejewska, I; Supruniuk, K, 2021
)
1.59
"Rosmarinic acid (RA) is a natural phenolic compound that acts as a Fyn inhibitor by 53 homology modeling of the human Fyn structure. "( Rosmarinic Acid Induces Proliferation Suppression of Hepatoma Cells Associated with NF-κB Signaling Pathway.
An, L; An, Y; Hao, H; Hu, J; Qiao, Y; Tao, Y; Wu, W; Zhang, Y; Zhao, J, 2021
)
3.51
"Rosmarinic acid (RA) is a phenolic ester included in various medicinal herbs such as Salvia miltiorrhiz and Perilla frutescens."( Rosmarinic acid suppresses colonic inflammation in dextran sulphate sodium (DSS)-induced mice via dual inhibition of NF-κB and STAT3 activation.
An, HJ; Cheon, SY; Chung, KS; Hwang, S; Jin, BR; Lee, M; Noh Hwang, S; Rhee, KJ, 2017
)
2.62
"Rosmarinic acid (RA) is a polyphenol antioxidant with many biological activities, including anti-UV and anti-tumor properties."( Inhibitory effects of rosmarinic acid on pterygium epithelial cells through redox imbalance and induction of extrinsic and intrinsic apoptosis.
Chen, YY; Hsu, YW; Lu, FJ; Tsai, CF; Tsai, MC, 2017
)
1.49
"Rosmarinic acid is a polyphenol antioxidant that can scavenge radiation-induced ROS, but the structure prevents it from accumulating in mitochondria."( Synthesis and Characterization of a Rosmarinic Acid Derivative that Targets Mitochondria and Protects against Radiation-Induced Damage In Vitro.
Kang, XM; Li, YY; Wang, HN; Wang, HW; Wang, JY; Xu, WQ; Zhang, YR, 2017
)
1.45
"Rosmarinic acid (RosA) is a water-soluble polyphenol, which can be isolated from many herbs such as orthosiphon diffuses and rosmarinus officinalis. "( Rosmarinic acid down-regulates NO and PGE
Bao, JP; Chen, WP; Hu, PF; Jin, GJ; Wu, LD; Xiong, Y, 2018
)
3.37
"Rosmarinic acid (RA) is a phenolic compound with biological activity. "( Serum Albumin Modulates the Bioactivity of Rosmarinic Acid.
Ascensão, L; Brito, E; Falé, PLV; Haris, PI; Pacheco, R; Serralheiro, A; Serralheiro, ML; Silva, A, 2018
)
2.19
"Rosmarinic acid (RA) is a highly valued natural phenolic compound that is very commonly found in plants of the families Lamiaceae and Boraginaceae, including Coleus blumei, Heliotropium foertherianum, Rosmarinus officinalis, Perilla frutescens, and Salvia officinalis. "( Anticancer potential of rosmarinic acid and its improved production through biotechnological interventions and functional genomics.
Ghasemzadeh, A; Sinniah, UR; Swamy, MK, 2018
)
2.23
"Rosmarinic acid (RA) is a natural phenylpropanoid with numerous pharmacological activities. "( Rosmarinic acid influences collagen, MMPs, TIMPs, glycosylation and MUC1 in CRL-1739 gastric cancer cell line.
Bielawska, A; Galicka, A; Karna, E; Nazaruk, J; Popławska, B; Radziejewska, I; Supruniuk, K, 2018
)
3.37
"Rosmarinic acid is a bioactive phytochemical that can be found in many herbs as ethnomedicines. "( Review on rosmarinic acid extraction, fractionation and its anti-diabetic potential.
Chua, LS; Lau, CH; Ngo, YL, 2018
)
2.33
"Rosmarinic acid (RA) is a naturally occurring polyphenolic compound. "( Rosmarinic acid protects against MPTP-induced toxicity and inhibits iron-induced α-synuclein aggregation.
Jia, W; Jiang, H; Qu, L; Xie, J; Xu, H, 2019
)
3.4
"Rosmarinic acid (RA) is a natural polyphenol which possesses the ability to inhibit BC cell proliferation and demonstrates cytotoxic properties against those cells."( Expression profiling of genes modulated by rosmarinic acid (RA) in MCF-7 breast cancer cells.
Bogacz, A; Czerny, B; Juskowiak, B; Kamiński, A; Seremak-Mrozikiewicz, A; Uzar, I; Wolek, M, 2018
)
1.46
"Rosmarinic acid (RA) is a natural phenolic compound found mainly in the family Lamiaceae consisting of several medicinal plants, herbs and spices."( Hepatoprotective effects of rosmarinic acid: Insight into its mechanisms of action.
Elufioye, TO; Habtemariam, S, 2019
)
1.53
"Rosmarinic acid (RA) is a common phenolic compound."( Rosmarinic acid exerts an antagonistic effect on vascular calcification by regulating the Nrf2 signalling pathway.
Bao, L; Fu, Y; Gao, C; Ji, R; Jin, Y; Luo, C; Ma, X; Peng, J; Sun, H; Sun, S; Zhang, X, 2019
)
2.68
"Rosmarinic acid (RA) is a caffeic acid derivative and one of the most abundant and bioactive constituents in Java tea (Orthosiphon stamineus), which has significant biological activities. "( Metabolic profile of rosmarinic acid from Java tea (Orthosiphon stamineus) by ultra-high-performance liquid chromatography coupled to quadrupole-time-of-flight tandem mass spectrometry with a three-step data mining strategy.
Feng, Y; Luo, Y; Qian, K; Tan, T; Wen, Q; Zhang, J, 2019
)
2.28
"Rosmarinic acid (RA) is an ester of caffeic acid and 3,4-dihydroxyphenylactic acid that prevents cell damage caused by free radicals, acting as an antioxidant."( Rosmarinic acid improves oxidative stress parameters and mitochondrial respiratory chain activity following 4-aminopyridine and picrotoxin-induced seizure in mice.
da Rosa, MS; Gonçalves, D; Leipnitz, G; Luft, JG; Morás, AM; Moura, DJ; Pereira, P; Pflüger, PF; Regner, GG; Steffens, L, 2019
)
2.68
"Rosmarinic acid (RA) is a natural pure compound from herbs belonging to the Lamiaceae family, such as rosemary, sage, basil, and mint. "( Rosmarinic acid improves hypertension and skeletal muscle glucose transport in angiotensin II-treated rats.
Buniam, J; Chukijrungroat, N; Prasannarong, M; Rattanavichit, Y; Saengsirisuwan, V; Surapongchai, J, 2019
)
3.4
"In Rosmarinic Acid (RA) is a phenolic acid which has many biological activities such as antioxidant, anti inflammatory and anti viral effects. "( Anti herpes simplex-1 activity of a standard extract of Zataria multiflora Boiss.
Ansari-Dogaheh, M; Arabzadeh, AM; Heidarbeigi, M; Shakibaie, M; Sharififar, F, 2013
)
1.01
"Rosmarinic acid (RA) is an important component of Chinese herbal medicine treatments and has been demonstrated to exert therapeutic effects in mood disorders. "( Rosmarinic acid ameliorates PTSD-like symptoms in a rat model and promotes cell proliferation in the hippocampus.
Chen, Y; Fang, Z; Gao, F; Hou, W; Lao, N; Li, X; Nie, H; Peng, Z; Tan, Q; Wang, H; Xiong, L, 2014
)
3.29
"Rosmarinic acid (RA) is a natural phenolic compound with a broad range of applications, from food preservatives to cosmetics. "( Nephroprotective activities of rosmarinic acid against cisplatin-induced kidney injury in mice.
Crnčević-Orlić, Z; Domitrović, R; Potočnjak, I; Škoda, M, 2014
)
2.13
"Rosmarinic acid is an ester of caffeic acid with interesting biological activities including antioxidant effects and scavenging of oxygen-free radicals."( Radiosensitizing effect of rosmarinic acid in metastatic melanoma B16F10 cells.
Achel, DG; Alcaraz, M; Alcaraz-Saura, M; Castillo, J; López-Morata, JA; Olivares, A, 2014
)
2.14
"Rosmarinic acid (RA) is a good antioxidant and health care product, but the roles of RA in muscle cells damage and the mechanisms which caused by high temperature is still unknown."( The protective effect of rosmarinic acid on hyperthermia-induced C2C12 muscle cells damage.
Chen, KL; Li, HX; Xu, XL; Zhou, GH, 2014
)
1.43
"Rosmarinic acid (RA) is a polyphenolic compound that shows a number of interesting biological activities, such as antiapoptotic, antifibrotic, antioxidant, hepatoprotective, antineurodegenerative, and anti-inflammatory properties. "( Chemopreventive effects of rosmarinic acid on rat colon carcinogenesis.
Cleto, SS; Cunha, WR; Furtado, RA; Munari, CC; Oliveira, BR; Silva, LR; Tavares, DC, 2015
)
2.16
"Rosmarinic acid is a polyphenolic compound and main constituent of Rosmarinus officinalis and has been shown to possess antioxidant and anti-inflammatory properties. "( Anti-inflammatory effect of rosmarinic acid and an extract of Rosmarinus officinalis in rat models of local and systemic inflammation.
Barateiro, A; Brites, D; Bronze, R; Duarte, CM; Eduardo-Figueira, M; Fernandes, A; Fernandes, E; Freitas, M; Mota-Filipe, H; Pinto, R; Rocha, J; Sepodes, B; Serra, AT; Silva-Lima, B, 2015
)
2.15
"Rosmarinic acid (RA) is a natural phenol that exerts different biological activities, such as antioxidant activity and neuroprotective effects. "( Ameliorative effect of rosmarinic acid on scopolamine-induced memory impairment in rats.
Hasanein, P; Mahtaj, AK, 2015
)
2.17
"Rosmarinic acid (RA), which is a natural polyphenol, was isolated from Rosmarinus. "( Effects of rosmarinic acid on liver and kidney antioxidant enzymes, lipid peroxidation and tissue ultrastructure in aging mice.
Chen, X; Lu, Q; Yang, L; Zhang, Y; Zu, Y, 2015
)
2.25
"Rosmarinic acid (RA) is a natural polyphenol with antioxidant, anti-apoptotic, and anti-inflammatory properties."( Rosmarinic acid exerts a neuroprotective effect in the kainate rat model of temporal lobe epilepsy: Underlying mechanisms.
Hasanzadeh, G; Khamse, S; Mohammadian, M; Roghani, M; Sadr, SS, 2015
)
2.58
"Rosmarinic acid (RA) is a natural polyphenolic antioxidant derived from many common herbal plants. "( Therapeutic and nutraceutical potential of rosmarinic acid-Cytoprotective properties and pharmacokinetic profile.
Campos, D; Gomes, AM; Madureira, AR; Nunes, S; Pintado, M; Reis, F; Sarmento, B, 2017
)
2.16
"Rosmarinic acid (RA) is an importantly and naturally occurring polyphenol from plants of the mint family with potent biological activities. "( Deciphering the binding patterns and conformation changes upon the bovine serum albumin-rosmarinic acid complex.
He, Z; Huang, R; Peng, X; Qi, W; Su, R; Wang, X, 2015
)
2.08
"Rosmarinic acid (RA) is a natural polyphenol contained in many aromatic plants with promising biological activities. "( Affinity of rosmarinic acid to human serum albumin and its effect on protein conformation stability.
He, Z; Peng, X; Qi, W; Su, R; Wang, X, 2016
)
2.26
"Rosmarinic acid (RA) is a phenolic compound commonly found in various plants, which has many biological activities including antioxidant activity."( Does rosmarinic acid treatment have protective role against sepsis-induced oxidative damage in Wistar Albino rats?
Aydın, S; Bacanlı, M; Başaran, AA; Başaran, N; Göktaş, HG; Şahin, T; Taner, G, 2016
)
1.67
"Rosmarinic acid (RA) is a natural polyphenol contained in many aromatic plants with promising biological activities. "( Rosmarinic acid inhibits some metabolic enzymes including glutathione S-transferase, lactoperoxidase, acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase isoenzymes.
Alwasel, SH; Bingöl, Z; Çetinkaya, S; Gülçin, İ; Huyut, Z; Koksal, Z; Scozzafava, A; Supuran, CT; Turkan, F, 2016
)
3.32
"Rosmarinic acid (RA) is an ester of caffeic acid and 3, 4-dihydroxyphenyl lactic acid. "( Protective effects of rosmarinic acid against radiation-induced damage to the hematopoietic system in mice.
Shen, X; Xu, W; Yang, F; Zhang, Y, 2016
)
2.19
"Rosmarinic acid (RA) is a polyphenolic ester of caffeic acid and is commonly found in the Nepetoideae subfamily of flowering mint plants. "( Acute rosmarinic acid treatment enhances long-term potentiation, BDNF and GluR-2 protein expression, and cell survival rate against scopolamine challenge in rat organotypic hippocampal slice cultures.
Choi, GY; Hwang, ES; Kim, HB; Kim, S; Lee, S; Lee, SO; Park, JH, 2016
)
2.36
"Rosmarinic acid is a naturally occurring substance which displays several biological effects including antioxidant and neuroprotective activity."( Rosmarinic acid is anticonvulsant against seizures induced by pentylenetetrazol and pilocarpine in mice.
Freitas, ML; Furian, AF; Grauncke, AC; Grigoletto, J; Oliveira, CV; Oliveira, MS; Santos, AR; Souto, NS; Souza, TL, 2016
)
2.6
"Rosmarinic acid (RA) is a natural substance that may be useful for treating diabetes mellitus. "( Rosmarinic acid ameliorates hyperglycemia and insulin sensitivity in diabetic rats, potentially by modulating the expression of PEPCK and GLUT4.
Amitani, H; Amitani, M; Asakawa, A; Cheng, KC; Inui, A; Kairupan, BH; Morinaga, A; Runtuwene, J; Takimoto, Y, 2016
)
3.32
"Rosmarinic acid (RA) is an active component of a traditional Chinese herbal medicine. "( Therapeutic effects of rosmarinic acid on airway responses in a murine model of asthma.
Deng, X; He, J; Liang, Z; Nie, H; Peng, J; Qiu, J; Wei, Y; Wen, X; Xu, Y; Zeng, Y; Zhong, W, 2016
)
2.19
"Rosmarinic acid (RA) is a natural antioxidant that has many biological activities. "( Rosmarinic acid reverses the effects of metronidazole-induced infertility in male albino rats.
Al-Alami, ZM; Shraideh, ZA; Taha, MO, 2017
)
3.34
"Rosmarinic acid (RA) is a natural phenolic compound which presents different biological activities such as antitumor, antibacterial, anti-inflammatory, hepatoprotective and cardioprotective properties. "( Antimutagenicity of rosmarinic acid in Swiss mice evaluated by the micronucleus assay.
Cunha, WR; de Almeida, LC; Furtado, MA; Furtado, RA; Tavares, DC, 2008
)
2.11
"Rosmarinic acid (RA) is a phenolic derivative of caffeic acid present in rosemary (Rosmarinus officinalis)."( Rosmarinic acid antagonizes activator protein-1-dependent activation of cyclooxygenase-2 expression in human cancer and nonmalignant cell lines.
Degner, SC; Romagnolo, DF; Scheckel, KA, 2008
)
2.51
"Rosmarinic acid (RA) is a naturally occurring polyphenolic compound. "( Rosmarinic acid inhibits 6-OHDA-induced neurotoxicity by anti-oxidation in MES23.5 cells.
Jiang, H; Li, R; Ren, P; Song, N; Wang, J; Xie, JX; Xu, HM, 2009
)
3.24
"Rosmarinic acid (RA) is a naturally occurring phenolic compound, which contributes to the beneficial and health-promoting effects of herbs, spices and medicinal plants. "( Protective effect of rosmarinic acid on V79 cells evaluated by the micronucleus and comet assays.
Cunha, WR; de Araújo, FR; Furtado, RA; Resende, FA; Tavares, DC, 2010
)
2.12
"Rosmarinic acid is a major phenylpropanoid isolated from Prunella vulgaris L., which is a composition of herbal tea for centuries in China. "( Anti-invasion effect of rosmarinic acid via the extracellular signal-regulated kinase and oxidation-reduction pathway in Ls174-T cells.
Liu, J; Liu, L; Xu, D; Xu, G; Xu, Y, 2010
)
2.11
"Rosmarinic acid (RA) is a naturally occurring polyphenolic compound found in various plant families. "( Rosmarinic acid antagonized 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in MES23.5 dopaminergic cells.
Du, T; Jiang, H; Li, L; Song, N; Xie, J, 2010
)
3.25
"Rosmarinic acid (RA) is a secondary metabolite that is frequently found in herbs, and has anti-inflammatory, anti-oxidant, and anti-microbial effects."( Rosmarinic acid attenuates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice.
Jang, AH; Jin, YH; Kim, GD; Kim, HJ; Kim, JE; Kim, SS; Kim, TH; Park, CS; Park, YS, 2011
)
2.53
"Rosmarinic acid (RA) is a naturally occurring phenolic acid."( Effect of rosmarinic acid on experimental diabetic nephropathy.
Hou, J; Jiang, WL; Xu, Y; Zhang, SP; Zhu, HB, 2012
)
1.5
"Rosmarinic acid (RA) is a naturally occurring polyphenolic compound. "( Neurorescue effect of rosmarinic acid on 6-hydroxydopamine-lesioned nigral dopamine neurons in rat model of Parkinson's disease.
Du, X; Jiang, H; Sun, P; Wang, J; Xie, J; Xu, H, 2012
)
2.14
"Rosmarinic acid (RA) is an important antioxidant polyphenol that is found in a variety of spices and herbs, including Ocimum canum Sims (locally called eme or akokobesa in Ghana). "( Rosmarinic acid content in antidiabetic aqueous extract of Ocimum canum sims grown in Ghana.
Affum, AO; Berhow, MA; Gyan, BA, 2012
)
3.26
"Rosmarinic acid (RA) is an important component of the leaves of Perilla frutescens and has neuroprotective, anti-microbial, anti-oxidant, and anti-cancer effects but little is known of its effects on HMGB1-mediated inflammatory response."( Barrier protective effects of rosmarinic acid on HMGB1-induced inflammatory responses in vitro and in vivo.
Bae, JS; Ku, SK; Lee, S; Lee, T; Lee, W; Song, KS; Yang, EJ, 2013
)
1.4
"Rosmarinic acid is known to be a natural phenolic compound widely distributed in Labiatae herbs such as rosemary, sweet basil, and perilla. "( Suppressive effects of rosmarinic acid on mesangioproliferative glomerulonephritis in rats.
Honda, G; Liu, N; Makino, T; Muso, E; Nakamura, T; Ono, T, 2002
)
2.07
"Rosmarinic acid is an ester of caffeic acid and 3,4-dihydroxyphenyllactic acid. "( Rosmarinic acid.
Petersen, M; Simmonds, MS, 2003
)
3.2
"Rosmarinic acid (RosA) is a hydroxylated compound frequently found in herbal plants and is mostly responsible for anti-inflammatory and antioxidative activity. "( Rosmarinic acid inhibits Ca2+-dependent pathways of T-cell antigen receptor-mediated signaling by inhibiting the PLC-gamma 1 and Itk activity.
Kang, MA; Won, J; Yun, SY, 2003
)
3.2
"Rosmarinic acid is a naturally occurring polyphenol with antioxidative and anti-inflammatory activities."( Rosmarinic acid inhibits lung injury induced by diesel exhaust particles.
Inoue, K; Kato, Y; Natsume, M; Osakabe, N; Osawa, T; Sanbongi, C; Sasa, N; Takano, H; Yanagisawa, R; Yoshikawa, T, 2003
)
2.48
"Rosmarinic acid (RA) is a natural polyphenolic substance contained in many Lamiaceae herbs such as Perilla frutescens. "( Absorption, metabolism, degradation and urinary excretion of rosmarinic acid after intake of Perilla frutescens extract in humans.
Baba, S; Hiyoshi, K; Muto, Y; Natsume, M; Osakabe, N; Takano, H; Terao, J; Yasuda, A; Yoshikawa, T, 2005
)
2.01
"Rosmarinic acid is an ester of caffeic acid and 3,4-dihydroxyphenyllactic acid [2-O-cafeoil-3-(3,4-di-hydroxy-phenyl)-R-lactic acid]."( Rosmarinic acid, a new snake venom phospholipase A2 inhibitor from Cordia verbenacea (Boraginaceae): antiserum action potentiation and molecular interaction.
Cambraia, RS; Fontes, MR; França, SC; Giglio, JR; Hage, LI; Magro, AJ; Pereira, PS; Sampaio, SV; Soares, AM; Stábeli, RG; Ticli, FK, 2005
)
2.49
"Rosmarinic acid is a naturally occurring hydroxylated compound. "( Neurobehavioral and genotoxic aspects of rosmarinic acid.
Ardenghi, P; da Silva Brum, LF; Oliveira, P; Pereira, P; Picada, JN; Tysca, D, 2005
)
2.04
"Rosmarinic acid (RA) is a naturally occurring polyphenolic and is found in several herbs in the Lamiaceae family, such as, Perilla frutescens. "( Inhibitory effects of rosmarinic acid on adriamycin-induced apoptosis in H9c2 cardiac muscle cells by inhibiting reactive oxygen species and the activations of c-Jun N-terminal kinase and extracellular signal-regulated kinase.
Chae, HJ; Chae, SW; Hong, ST; Kim, DS; Kim, HR; Woo, ER, 2005
)
2.09
"Rosmarinic acid (Ros A) is a secondary metabolite of certain herbs and has multiple biological activities, including anti-inflammatory effects."( Prolonged survival of islet allografts in mice treated with rosmarinic acid and anti-CD154 antibody.
Joh, JW; Joo, SY; Jung, DY; Kim, EY; Kim, SH; Kim, SJ; Kwon, CH; Kwon, GY; Moon, C; Park, JB; Sim, EY, 2008
)
1.31
"Rosmarinic acid is a phenolic compound widely distributed in Labiatae herbs such as rosemary, sweet basil, and perilla, which are frequently used with meat and fish dishes in Western and Asian countries. "( Inhibitory effects of rosmarinic acid on the proliferation of cultured murine mesangial cells.
Honda, G; Makino, T; Muso, E; Ono, T; Sasayama, S; Yoshida, H, 2000
)
2.06
"Rosmarinic acid (RA) is a nonsteroidal anti-inflammatory agent. "( Percutaneous absorption of rosmarinic acid in the rat.
Hussain, AS; Koch, HP; Ritschel, WA; Sabouni, A; Starzacher, A, 1989
)
2.02
"Rosmarinic acid (RA) is a naturally occurring compound, isolated from Rosmarinus officinalis or Melissa officinalis which inhibits the in vitro immunohaemolysis of antibody-coated sheep erythrocytes by guinea pig serum. "( Rosmarinic acid: a new inhibitor of complement C3-convertase with anti-inflammatory activity.
Englberger, W; Etschenberg, E; Graf, E; Hadding, U; Leyck, S; Parnham, MJ; Winkelmann, J, 1988
)
3.16

Effects

Rosmarinic acid (RA) has a wide range of biological effects, including the antioxidation and antiaging. It has an increased capacity for producing radio-induced damage, and thus a paradoxical damaging effect in melanoma cells.

Rosmarinic acid (RA) has antioxidation, anticancer, antibacterial, anti-inflammatory and various biological functions. It might be a useful agent for protecting central nervous system against age related alterations.

ExcerptReferenceRelevance
"Rosmarinic acid (RA) has a wide range of biological effects, including the antioxidation and antiaging. "( Rosmarinic acid improved antioxidant properties and healthspan via the IIS and MAPK pathways in Caenorhabditis elegans.
Cao, Y; Chen, Y; Lin, C; Xi, Y; Xiao, J; Zhang, X; Zheng, H; Zhong, Q, 2019
)
3.4
"Rosmarinic acid has an increased capacity for producing radio-induced damage, and thus a paradoxical damaging effect in melanoma cells. "( Radiosensitizing effect of rosmarinic acid in metastatic melanoma B16F10 cells.
Achel, DG; Alcaraz, M; Alcaraz-Saura, M; Castillo, J; López-Morata, JA; Olivares, A, 2014
)
2.14
"Rosmarinic acid (RA) has an anti-inflammatory property while thymic stromal lymphopoietin (TSLP) has an important role in mast cell-mediated inflammatory responses. "( Inhibition of MDM2 expression by rosmarinic acid in TSLP-stimulated mast cell.
Jeong, HJ; Kim, HM; Kim, MH; Park, CL; Yoou, MS, 2016
)
2.16
"Rosmarinic acid (RA) has a number of interesting biological activities, e.g. "( Microencapsulation of rosmarinic acid using polycaprolactone and various surfactants.
Jeong, HH; Kang, KC; Kim, HJ; Kim, TH; Pyo, HB, 2010
)
2.12
"Rosmarinic acid has a number of interesting biological activities, e.g."( Rosmarinic acid.
Petersen, M; Simmonds, MS, 2003
)
2.48
"Rosmarinic acid (RA) has been shown to exert anti-tumor effects on various types of cancer. "( Rosmarinic Acid Decreases the Malignancy of Pancreatic Cancer Through Inhibiting Gli1 Signaling.
Bai, Y; Chen, L; Deng, J; Li, Z; Liu, R; Ruan, Q; Wang, W; Wen, C; Xu, J; Xu, Z; Zhou, X, 2022
)
3.61
"Rosmarinic acid (RA) has been shown to have a significant anti-neuroinflammatory effect."( Rosmarinic acid relieves LPS-induced sickness and depressive-like behaviors in mice by activating the BDNF/Nrf2 signaling and autophagy pathway.
Li, Y; Qi, K; Wei, Y; Xu, W; Yu, Y, 2022
)
2.89
"Rosmarinic acid (RA) has obvious anti-inflammatory and antioxidant effects, so we evaluated the anti-inflammatory and antioxidant effects of RA pretreatment on serum and liver and kidney tissues of cisplatin (CP)-treated mice and explored the possible mechanisms."( Rosmarinic Acid Prevents Cisplatin-Induced Liver and Kidney Injury by Inhibiting Inflammatory Responses and Enhancing Total Antioxidant Capacity, Thereby Activating the Nrf2 Signaling Pathway.
Deng, R; Deng, Z; Feng, X; He, J; Ji, M; Liang, Q; Liu, X; Lv, L; Ren, L; Wu, L; Xiang, Y, 2022
)
2.89
"Rosmarinic acid (RA) has been proven to exert antianaphylaxis in atopic dermatitis, asthma, and allergic rhinitis. "( Hepatoprotective Effects of Rosmarinic Acid on Ovalbumin-Induced Intestinal Food Allergy Mouse Model.
Fang, M; Gong, Z; Jia, B; Liu, X; Shang, J; Wang, X; Wu, K; Xu, L; Yang, Q; Zeng, H, 2023
)
2.65
"Rosmarinic acid has antioxidant properties and is an effective hepatoprotective agent. "( Investigation of antioxidant effects of rosmarinic acid on liver, lung and kidney in rats: a biochemical and histopathological study.
Aday, U; Alabalik, U; Böyük, A; Deveci, E; Ekinci, A; Ekingen, A; Gültürk, B; Oğuz, A; Tuncer, MC; Türkoğlu, A, 2020
)
2.27
"Rosmarinic acid has been reported to exhibit anti-inflammatory and anti-oxidant activity but the factors affecting the content of rosmarinic acid in plants remain unknown."( Rosmarinic acid in Perilla frutescens and perilla herb analyzed by HPLC.
Deguchi, Y; Ito, M, 2020
)
2.72
"Rosmarinic acid (RA) has already been verified to efficiently protect cells from oxidant-induced injury and to produce significant effect on cryopreservation of semen."( Boar sperm quality and oxidative status as affected by rosmarinic acid at 17 °C.
Du, R; He, Y; Li, D; Pang, W; Tian, X; Yang, G; Yu, T; Zhang, W, 2020
)
1.53
"Rosmarinic acid has significant antinociceptive, neuroprotective, and neuroregenerative effects."( Effects of rosmarinic acid on nervous system disorders: an updated review.
Ghasemzadeh Rahbardar, M; Hosseinzadeh, H, 2020
)
1.67
"Rosmarinic acid (RA) has positive effects on the liver injuries; nevertheless, its mechanisms are not completely studied."( SIRT1/NFκB pathway mediates anti-inflammatory and anti-apoptotic effects of rosmarinic acid on in a mouse model of nonalcoholic steatohepatitis (NASH).
Bassirian, M; Changizi, Z; Komeili-Movahhed, T; Moslehi, A, 2022
)
1.67
"Rosmarinic acid (RA) has shown antioxidant, anti-inflammatory, and anticancer effects."( In Vivo and In Vitro Protective Effects of Rosmarinic Acid against Doxorubicin-Induced Cardiotoxicity.
Eisvand, F; Hosseinzadeh, H; Rahbardar, MG; Rameshrad, M; Razavi, BM, 2022
)
1.71
"Rosmarinic acid (RA), which has multiple bioactive properties, might be a useful agent for protecting central nervous system against age related alterations. "( Changes of auditory event-related potentials in ovariectomized rats injected with d-galactose: Protective role of rosmarinic acid.
Acun, AD; Er, H; Hidisoglu, E; Kantar-Gok, D; Olgar, Y; Yargıcoglu, P, 2017
)
2.11
"Rosmarinic acid (RA) has antioxidation, anticancer, antibacterial, anti-inflammatory and various biological functions. "( Rosmarinic acid protects mice from lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting MAPKs/NF-κB and activating Nrf2/HO-1 signaling pathways.
Feng, H; Jin, M; Li, Z; Liu, G; Shen, B; Tian, Y; Wang, Y; Wu, L; Zhang, Q, 2019
)
3.4
"Rosmarinic acid (RA) has a wide range of biological effects, including the antioxidation and antiaging. "( Rosmarinic acid improved antioxidant properties and healthspan via the IIS and MAPK pathways in Caenorhabditis elegans.
Cao, Y; Chen, Y; Lin, C; Xi, Y; Xiao, J; Zhang, X; Zheng, H; Zhong, Q, 2019
)
3.4
"Rosmarinic acid has an increased capacity for producing radio-induced damage, and thus a paradoxical damaging effect in melanoma cells. "( Radiosensitizing effect of rosmarinic acid in metastatic melanoma B16F10 cells.
Achel, DG; Alcaraz, M; Alcaraz-Saura, M; Castillo, J; López-Morata, JA; Olivares, A, 2014
)
2.14
"Rosmarinic acid has dual regulatory effects on bone metabolism and may control the bone functions by controlling osteoblastic and osteoclastic differentiation."( Rosmarinic acid exerts an antiosteoporotic effect in the RANKL-induced mouse model of bone loss by promotion of osteoblastic differentiation and inhibition of osteoclastic differentiation.
Asai, M; Cha, BY; Iimura, T; Jeon, SK; Lee, JW; Woo, JT; Yamaguchi, A; Yonezawa, T, 2015
)
3.3
"Rosmarinic acid (RA) has an anti-inflammatory property while thymic stromal lymphopoietin (TSLP) has an important role in mast cell-mediated inflammatory responses. "( Inhibition of MDM2 expression by rosmarinic acid in TSLP-stimulated mast cell.
Jeong, HJ; Kim, HM; Kim, MH; Park, CL; Yoou, MS, 2016
)
2.16
"Rosmarinic acid (RA) has numerous pharmacologic effects, including anti-oxidant, anti-inflammatory, and analgesic effects. "( Rosmarinic Acid Attenuates Airway Inflammation and Hyperresponsiveness in a Murine Model of Asthma.
Chu, X; Deng, X; He, J; Hu, T; Liang, Z; Nie, H; Wen, X; Xu, Y; Yang, J; Yang, X, 2016
)
3.32
"Rosmarinic acid (RA) has a number of interesting biological activities, e.g. "( Microencapsulation of rosmarinic acid using polycaprolactone and various surfactants.
Jeong, HH; Kang, KC; Kim, HJ; Kim, TH; Pyo, HB, 2010
)
2.12
"Rosmarinic acid (RA) has been demonstrated to have antioxidant, free radical scavenger and anti-inflammatory effects."( Effect of rosmarinic acid on inhibition of gentamicin induced nephrotoxicity in rats.
Ahmadvand, H; Tavafi, M, 2011
)
1.49
"Rosmarinic acid has been demonstrated to be effective in preventing the aggregation of amyloid peptides in vitro and to delay the progression of the disease in animal models."( Natural compounds against Alzheimer's disease: molecular recognition of Aβ1-42 peptide by Salvia sclareoides extract and its major component, rosmarinic acid, as investigated by NMR.
Airoldi, C; Dias, C; Jimenez-Barbero, J; Marcelo, F; Martins, A; Nicotra, F; Rauter, AP; Sironi, E, 2013
)
1.31
"Rosmarinic acid has a number of interesting biological activities, e.g."( Rosmarinic acid.
Petersen, M; Simmonds, MS, 2003
)
2.48
"Rosmarinic acid has been reported to inhibit complement activation in vivo as well as in vitro. "( Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b.
Pangburn, MK; Rawal, N; Sahu, A, 1999
)
2
"Rosmarinic acid has been reported to have effects on both the classical pathway C3-convertase and on the cobra venom factor-induced, alternative pathway convertase."( The inhibitory effect of rosmarinic acid on complement involves the C5 convertase.
Charlesworth, JA; Martyn, P; Peake, PW; Pussell, BA; Timmermans, V, 1991
)
1.31

Actions

Rosmarinic acid does not cause significant changes in the permeability of planar bilayer membranes. It would suppress the proliferation of mesangial cells and glomerular matrix expansion in vivo by its fibrinolytic and anti-oxidative activity.

ExcerptReferenceRelevance
"Rosmarinic acid does not cause significant changes in the permeability of planar bilayer membranes in a dose range of 0.5 to 10 mkg/mL."( [Study of antioxidant and membrane activity of rosmarinic acid using different model systems].
Artiukov, AA; Korepanova, EA; Krivoshapko, ON; Osipov, AN; Popov, AM,
)
1.11
"Rosmarinic acid would suppress the proliferation of mesangial cells and glomerular matrix expansion in vivo by its fibrinolytic and anti-oxidative activity."( Suppressive effects of rosmarinic acid on mesangioproliferative glomerulonephritis in rats.
Honda, G; Liu, N; Makino, T; Muso, E; Nakamura, T; Ono, T, 2002
)
2.07

Treatment

The rosmarinic acid treatment decreased HBV components including the amounts of extracellular HBV DNA with negligible cytotoxicity. The treatment also inhibited the enhanced protein expression of IL-4 and IL-5, and eotaxin.

ExcerptReferenceRelevance
"The rosmarinic acid treatment decreased HBV components including the amounts of extracellular HBV DNA with negligible cytotoxicity."( Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction.
Chayama, K; Fujita, T; Ikeda, S; Kato, H; Narita, R; Otakaki, Y; Sakaguchi, T; Taguchi, R; Takeuchi, F; Tsukamoto, Y; Uwai, K; Wakita, T; Watashi, K; Yao, WL, 2018
)
2.4
"Rosmarinic acidtreated cells revealed significant changes in cell morphology including cellular shrinkage and cell rounding."( Anticancer effects of Rosmarinic acid in OVCAR-3 ovarian cancer cells are mediated via induction of apoptosis, suppression of cell migration and modulation of lncRNA MALAT-1 expression.
Cai, J; Cheng, XL; Hu, M; Liu, L; Wang, T; Zhang, Y; Zhou, J,
)
1.17
"Rosmarinic acid treatment also rescued impaired liver function due to PH."( Rosmarinic acid stimulates liver regeneration through the mTOR pathway.
Duan, E; He, Z; Hu, W; Lou, K; Xiao, Z; Yang, M; Yu, C; Zhang, L; Zhang, M; Zhang, R; Zhao, J, 2016
)
2.6
"Rosmarinic acid pretreatment restored the complex I activity of the mitochondrial respiratory chain and partially reversed the other damaging effects of MPP(+)."( Rosmarinic acid antagonized 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in MES23.5 dopaminergic cells.
Du, T; Jiang, H; Li, L; Song, N; Xie, J, 2010
)
2.52
"Rosmarinic acid in PE treatment also inhibited the enhanced protein expression of IL-4 and IL-5, and eotaxin in the lungs of sensitized mice."( Rosmarinic acid in perilla extract inhibits allergic inflammation induced by mite allergen, in a mouse model.
Ichinose, T; Inoue, KI; Natsume, M; Osakabe, N; Sadakane, K; Sanbongi, C; Sasa, N; Takano, H; Yanagisawa, R; Yoshikawa, T, 2004
)
2.49
"Treatment of rosmarinic acid also resulted in endoplasmic reticulum stress and affected negatively the migratory potential of cancer cells in a concentration-dependent manner."( Anticancer effects of rosmarinic acid in human oral cancer cells is mediated via endoplasmic reticulum stress, apoptosis, G2/M cell cycle arrest and inhibition of cell migration.
Chen, L; Cheng, Z; Luo, Y; Ma, Z; Qi, H; Xu, X,
)
0.8
"With treatment of rosmarinic acid, retinal endothelial cells in G2/M phase increased whereas those in G0/G1 and S phases decreased, which was accompanied by increase of p21(WAF1) expression in a dose-dependent manner."( Rosmarinic acid suppresses retinal neovascularization via cell cycle arrest with increase of p21(WAF1) expression.
Kim, JH; Kim, KW; Kim, MY; Lee, BJ; Yu, YS, 2009
)
2.12

Toxicity

ExcerptReferenceRelevance
" After preincubation of cardiomyocytes with the test compounds (100, 200 microm; 1 h) the cardiomyocytes were treated with the toxic agent, DOX (100 microm; 8 h)."( Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part II. caffeic, chlorogenic and rosmarinic acids.
Chlopcíková, S; Lichnovský, V; Miketová, P; Psotová, J; Simánek, V; Sousek, J, 2004
)
0.53
" Tested at doses up to 5000 μg/plate, the Orthosiphon stamineus extract was not toxic to Salmonella tester strains and did not increase the number of revertant colonies over the background incidence."( Evaluation of the genotoxicity of Orthosiphon stamineus aqueous extract.
Afzan, A; De-Oliveira, AC; Gomes-Carneiro, MR; Ismail, Z; Muhammad, H; Paumgartten, FJ; Poça, KS; Sulaiman, SA, 2011
)
0.37
"The beneficial or adverse effects of isolated phytochemicals are not always concordant with effects of the botanical dietary supplements from which they were derived."( Use of the Combination Index to determine interactions between plant-derived phenolic acids on hepatotoxicity endpoints in human and rat hepatoma cells.
Ferguson, MS; Flynn, TJ; Hoagland, EM; Liu, Y, 2013
)
0.39
"Cadmium ( Cd(2+) ) is an environmental contaminant that causes a variety of adverse effects."( Protective effect of rosmarinic acid is through regulation of inflammatory cytokine in cadmium-induced ototoxicity.
Hong, SH; Kim, SH; Kim, SJ; Um, JY, 2013
)
0.71
" Cr (VI) was less toxic for immature neurons."( Cr (VI) induced oxidative stress and toxicity in cultured cerebellar granule neurons at different stages of development and protective effect of Rosmarinic acid.
Amani, N; Dashti, A; Soodi, M, 2016
)
0.63
" No adverse event was reported by any of the participants due to the study treatment."( Pharmacokinetics, Safety and Tolerability of Melissa officinalis Extract which Contained Rosmarinic Acid in Healthy Individuals: A Randomized Controlled Trial.
Hamaguchi, T; Iwasa, K; Kobayashi, S; Nagai, T; Nakamura, H; Noguchi-Shinohara, M; Ono, K; Yamada, M, 2015
)
0.64
"15 mg/mL, presented a safe profile, while genotoxic potential was found for the higher dose (1."( Safety profile of solid lipid nanoparticles loaded with rosmarinic acid for oral use: in vitro and animal approaches.
Calhau, C; Campos, DA; Fernandes, JC; Gomes, AM; Gullón, B; Madureira, AR; Marques, C; Nunes, S; Pintado, MM; Reis, F; Rodríguez-Alcalá, LM; Sarmento, B; Zuzarte, M, 2016
)
0.68
"Casein and SPI protein formulations warranted high bioefficacy of marjoram extract, showing their potential as safe carriers."( Protein matrices ensure safe and functional delivery of rosmarinic acid from marjoram (Origanum majorana) extracts.
Arranz, E; Corredig, M; Guri, A; Jaime, L; Ortego-Hernández, E; Reglero, G; Santoyo, S; Villalva, M, 2019
)
0.76
" Toxic concentration ranges were determined by the brine shrimp lethality test on Artemia salina."( Cytotoxic Effects of Resveratrol, Rutin and Rosmarinic Acid on ARH-77 Human (Multiple Myeloma) Cell Line.
Artagan, O; Canturk, Z; Dikmen, M; Ozarda, MG; Ozturk, N, 2016
)
0.7
" No serious adverse events occurred."( Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer's disease progression.
Hamaguchi, T; Iwasa, K; Kobayashi, S; Komatsu, J; Nagai, T; Nakamura, H; Noguchi-Shinohara, M; Ono, K; Samuraki-Yokohama, M; Yamada, M; Yokoyama, K, 2020
)
0.8
" Administration of RA ameliorated the toxic effects of DOX."( In Vivo and In Vitro Protective Effects of Rosmarinic Acid against Doxorubicin-Induced Cardiotoxicity.
Eisvand, F; Hosseinzadeh, H; Rahbardar, MG; Rameshrad, M; Razavi, BM, 2022
)
0.98
" Since the observed effects were reversed by flumazenil and no side effect on the memory and muscle strength was reported, modulation of the α1-containing GABA-A receptors could be proposed as one of the involved mechanisms."( Sedative-hypnotic, anxiolytic and possible side effects of Salvia limbata C. A. Mey. Extracts and the effects of phenological stage and altitude on the rosmarinic acid content.
Behzad, S; Faizi, M; Jahani, R; Saffariha, M; Toufan Tabrizi, N, 2022
)
0.92

Pharmacokinetics

ExcerptReferenceRelevance
" This method has been successfully applied in the simultaneous quantification and the pharmacokinetic studies of these six compounds in animals which were orally administered with danshen preparations."( Simultaneous determination of danshensu, rosmarinic acid, cryptotanshinone, tanshinone IIA, tanshinone I and dihydrotanshinone I by liquid chromatographic-mass spectrometry and the application to pharmacokinetics in rats.
Li, X; Li, Y; Liu, Y; Wang, L; Xue, M, 2010
)
0.63
" The method was successfully applied to a pharmacokinetic study in rats after an intravenous administration of Danshen injection."( Simultaneous determination of six phenolic constituents of Danshen injection in rat plasma by LC-ESI-MS and its application to a pharmacokinetic study.
Chen, XJ; Han, DE; He, JK; Li, N; Li, TT; Lu, Y; Yang, SY; Zhao, D, 2011
)
0.37
" The validated method was successfully applied in a pharmacokinetic study in rats after intravenous administration of Shenxiong glucose injection."( A UPLC-MS/MS method for simultaneous determination of danshensu, protocatechuic aldehyde, rosmarinic acid, and ligustrazine in rat plasma, and its application to pharmacokinetic studies of Shenxiong glucose injection in rats.
Gong, Z; Huang, Y; Lan, Y; Liu, Y; Lu, Y; Wang, A; Wang, Y; Xie, Y; Zheng, L, 2015
)
0.64
"The aim of this study was to investigate the pharmacokinetic interaction between tanshinones and polyphenolics which act as the main bioactive compounds in Saliva miltiorrhiza Bunge (SMB)."( Simultaneous determination of tanshinones and polyphenolics in rat plasma by UPLC-MS/MS and its application to the pharmacokinetic interaction between them.
Duan, J; Guan, H; Qian, D; Ren, H; Shang, E; Su, S; Zhang, W, 2016
)
0.43
" The quantitative retention-activity relationships (QRARs) of the constituents were established to model their pharmacokinetic (PK) parameters and chromatographic retention data, and generate their biological effectiveness fingerprints."( Determination of quantitative retention-activity relationships between pharmacokinetic parameters and biological effectiveness fingerprints of Salvia miltiorrhiza constituents using biopartitioning and microemulsion high-performance liquid chromatography.
Gao, H; Huang, H; Li, N; Yu, N; Zheng, A, 2017
)
0.46
" However, the pharmacokinetic behaviors of these compounds after their co-administration remain unclear."( Pharmacokinetic Assessments of Liquiritin, Protocatechuic Aldehyde and Rosmarinic Acid in Rat Plasma by UPLC-MS-MS After Administration of ZibuPiyin Recipe.
Xu, H; Zhan, L; Zhang, L, 2018
)
0.71
" The pharmacokinetic analysis of Sal B, Ros A and DA after pulmonary administration of SMPA solution to rat was performed by LC-MS/MS."( Pharmacokinetics of salvianolic acid B, rosmarinic acid and Danshensu in rat after pulmonary administration of Salvia miltiorrhiza polyphenolic acid solution.
Li, J; Liu, H; Liu, Z; Lu, P; Ma, Z; Peng, H; Xing, Y; Xue, Z; Zhang, B; Zhou, QT, 2019
)
0.78
" The aim of the current review is to present the fate of rosmarinic acid inside the human body, explained through pharmacokinetic steps and to briefly present the health benefits of RA."( Rosmarinic Acid-Human Pharmacokinetics and Health Benefits.
Božin, B; Gavarić, N; Hitl, M; Kladar, N, 2021
)
2.31
" In order to elucidate the underlying mechanisms of action, pharmacokinetic analysis is necessary."( Pharmacokinetic Analysis of Rosmarinic Acid and its Analog in Rat Plasma Using Liquid Chromatography-Tandem Mass Spectrometry.
Chen, K; Fu, S; Jiang, M; Jiang, W; Li, Q, 2022
)
1.02
" Nevertheless, the pharmacodynamic substance basis of this anti-insomnia effect is still unclear."( Screening out the anti-insomnia components from Prunella vulgaris L. based on plasma pharmacochemistry combined with pharmacodynamic experiments and UPLC-MS/MS analysis.
Cheng, FF; Jiang, YY; Lin, TF; Liu, B; Qiu, JN; Sun, M; Zhang, JH; Zhang, S; Zhang, Y, 2021
)
0.62
"The present study investigated the effects of ligustrazine hydrochloride(LH)-Salviae Miltiorrhizae Radix et Rhizoma(SM) before and after compatibility on the pharmacokinetics of acute myocardial ischemia(AMI) rats and revealed the mechanism of pharmacokinetic changes from the perspective of metabolic enzymes."( [Effects and correlation of ligustrazine hydrochloride-Salviae Miltiorrhizae Radix et Rhizoma compatibility on pharmacokinetics and CYP450 enzyme].
Li, R; Liu, CH; Liu, T; Lu, DY; Sun, J; Zhang, JY; Zheng, L, 2022
)
0.72

Compound-Compound Interactions

Study was to investigate the effect of chelating agents, ethylene diaminetetraacetic acid (EDTA) and rosmarinic acid (RA) on DNA integrity of freeze-dried boar sperm. Study aimed to evaluate the anti-tumor effects of ros Marinic acid combined with Adriamycin (ADM) on proliferation and apoptosis of hepatic carcinoma cell lines.

ExcerptReferenceRelevance
" This study was conducted to determine the effect of tomato lycopene alone, or in combination with other natural antioxidants, on LDL oxidation."( Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic.
Aviram, M; Fuhrman, B; Rosenblat, M; Volkova, N, 2000
)
0.53
" The objective of this study was to investigate the effect of chelating agents, ethylene diaminetetraacetic acid (EDTA) and ethylene glycoltetraacetic acid (EGTA), in combination with rosmarinic acid (RA) on DNA integrity of freeze-dried boar sperm."( Chelating agents in combination with rosmarinic acid for boar sperm freeze-drying.
de Blas, I; Domingo, P; Gil, L; González, N; Luño, V; Olaciregui, M, 2017
)
0.92
" This study aimed to evaluate the anti-tumor effects of rosmarinic acid (RosA) combined with Adriamycin (ADM) on proliferation and apoptosis of hepatic carcinoma cell lines."( Rosmarinic Acid Combined with Adriamycin Induces Apoptosis by Triggering Mitochondria-Mediated Signaling Pathway in HepG2 and Bel-7402 Cells.
Cai, Y; Huang, R; Huang, Y; Zheng, X, 2018
)
2.17
"s) or rosmarinic acid in combination with gemcitabine on Panc-1 pancreatic cancer cells."( Complementary effects of Orthosiphon stamineus standardized ethanolic extract and rosmarinic acid in combination with gemcitabine on pancreatic cancer.
Abdul Majid, AMS; Asif, M; Oon, CE; Yehya, AHS, 2021
)
1.33
" Animals in the treatment groups were subjected to uterine horn injection of RA, exosome, RA combination with exosome (R+E), and RA loaded to exosome (RLE) in uterine horn by two dosages in each group (5 and 10 mg/kg of RA or exosome), 24 h after inducing endometritis."( Enhanced anti-inflammatory effect of Rosmarinic acid by encapsulation and combination with the exosome in mice with LPS-induced endometritis through suppressing the TLR4-NLRP3 signaling pathway.
Asadpour, R; Fattahi, A; Jozani, RJ; Khordadmehr, M; Taravat, M, 2023
)
1.18

Bioavailability

Rosmarinic acid is well absorbed from gastrointestinal tract and from the skin. It is an attractive candidate for skin applications because of its antioxidant, anti-inflammatory, and photoprotective functions. Its poor bioavailability hampers its therapeutic outcome.

ExcerptReferenceRelevance
" Upon topical administration of RA in form of a W/O ointment (25 mg/kg, 50 cm2), the absolute bioavailability was 60%."( Percutaneous absorption of rosmarinic acid in the rat.
Hussain, AS; Koch, HP; Ritschel, WA; Sabouni, A; Starzacher, A, 1989
)
0.57
" Rosmarinic acid is well absorbed from gastrointestinal tract and from the skin."( Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials.
Abu-Amer, KM; al-Sereiti, MR; Sen, P, 1999
)
1.21
" We successfully identified novel lead compounds that did not contain phosphotyrosine moiety and might have an improved bioavailability as inhibitor for lck SH2 domain."( Design and synthesis of small chemical inhibitors containing different scaffolds for lck SH2 domain.
Kang, SH; Lee, KH; Lim, SH; Oh, HS; Park, SH, 2003
)
0.32
"RA and UA in herbal extracts had similar uptake as that found using the pure compounds, which may simplify the prediction of compound efficacy, but the apparent lack of intestinal glucuronidation/sulfation of UA is likely to further enhance the bioavailability of that compound compared with RA."( Permeability of rosmarinic acid in Prunella vulgaris and ursolic acid in Salvia officinalis extracts across Caco-2 cell monolayers.
Hauck, C; Hendrich, S; McCoy, JA; Murphy, PA; Qiang, Z; Reddy, MB; Widrlechner, MP; Ye, Z, 2011
)
0.72
" The present study is focused on the interference of flavonoids on the bioavailability of rosmarinic acid, as these types of compounds are often present together in decoctions of medicinal plants, namely Lamiaceae species."( Effect of luteolin and apigenin on rosmarinic acid bioavailability in Caco-2 cell monolayers.
Ascensão, L; Falé, PL; Serralheiro, ML, 2013
)
0.89
" The method was sensitive and reliable and was successfully applied to a pharmacokinetic and bioavailability study of Herba Isodi Rubescentis extract in rats."( Simultaneous determination of oridonin, ponicidin and rosmarinic acid from Herba Isodi Rubescentis extract by LC-MS-MS in rat plasma.
Li, J; Liu, Y; Ma, B; Wang, Y; Xu, Q; Ying, H; Zhang, Q,
)
0.38
" Lastly, we assessed the bioavailability and toxicity of these compounds using Lipinski's rule-of-five and ADMET analysis."( Inhibitors of the glyoxylate cycle enzyme ICL1 in Candida albicans for potential use as antifungal agents.
Cheah, HL; Lim, V; Sandai, D, 2014
)
0.4
" This review focuses on the importance of RA as a dietary supplement, and summarizes its pharmacokinetics and metabolism, including the factors that limit its oral bioavailability which leads to a lower therapeutic action."( Therapeutic and nutraceutical potential of rosmarinic acid-Cytoprotective properties and pharmacokinetic profile.
Campos, D; Gomes, AM; Madureira, AR; Nunes, S; Pintado, M; Reis, F; Sarmento, B, 2017
)
0.72
" The tanshinones improved the bioavailability of DSS, accelerated the eliminating rate of RA and Sal B and promoted their distribution in vivo."( Simultaneous determination of tanshinones and polyphenolics in rat plasma by UPLC-MS/MS and its application to the pharmacokinetic interaction between them.
Duan, J; Guan, H; Qian, D; Ren, H; Shang, E; Su, S; Zhang, W, 2016
)
0.43
" Considering the reduced bioavailability after oral use, effective (and safe) delivery systems are crucial to protect RA from gastrointestinal degradation."( Safety profile of solid lipid nanoparticles loaded with rosmarinic acid for oral use: in vitro and animal approaches.
Calhau, C; Campos, DA; Fernandes, JC; Gomes, AM; Gullón, B; Madureira, AR; Marques, C; Nunes, S; Pintado, MM; Reis, F; Rodríguez-Alcalá, LM; Sarmento, B; Zuzarte, M, 2016
)
0.68
" Phenolic bioavailability was tested using an in vitro digestion process followed by a Caco-2 cellular model of intestinal absorption."( Anti-Inflammatory and Antioxidant Activities from the Basolateral Fraction of Caco-2 Cells Exposed to a Rosmarinic Acid Enriched Extract.
Aguado, E; Jaime, L; Nieto, JA; Reglero, G; Santoyo, S; Villalva, M, 2018
)
0.7
" However, its poor bioavailability represents a limitation in terms of pharmacodynamics."( An overview of the neuroprotective potential of rosmarinic acid and its association with nanotechnology-based delivery systems: A novel approach to treating neurodegenerative disorders.
Bassani, VL; Braganhol, E; Fachel, FNS; Henriques, AT; Koester, LS; Schuh, RS; Teixeira, HF; Veras, KS, 2019
)
0.77
" The absolute bioavailability of Sal B increased at least 10-fold after pulmonary administration, compared with oral administration."( Pharmacokinetics of salvianolic acid B, rosmarinic acid and Danshensu in rat after pulmonary administration of Salvia miltiorrhiza polyphenolic acid solution.
Li, J; Liu, H; Liu, Z; Lu, P; Ma, Z; Peng, H; Xing, Y; Xue, Z; Zhang, B; Zhou, QT, 2019
)
0.78
" Despite the high therapeutic potential of RA, its intrinsic properties of poor water solubility and low bioavailability have limited its translation into the clinic."( Nanoparticles Derived from the Natural Antioxidant Rosmarinic Acid Ameliorate Acute Inflammatory Bowel Disease.
Chung, CH; Jon, S; Jung, W; Keum, H; Kim, TW, 2020
)
0.81
" Intravitreal devices allow for localized drug delivery to the posterior segment, increasing the drug bioavailability and promoting extended release, thus, reducing side effects and enhancing the patient's compliance to the treatment."( Rosmarinic Acid Intravitreal Implants: A New Therapeutic Approach for Ocular Neovascularization.
Castro, BFM; Cotta, OAL; Fialho, SL; Fulgêncio, GO; Moreira, CPS; Silva, LM; Silva-Cunha, A; Vieira, LC, 2020
)
2
" Our findings suggest that the use of chitosan/nutriose-coated niosomes to increase RA local bioavailability could be a promising nutraceutical strategy for oral colon-targeted UC therapy."( Anti-Inflammatory Effects of Rosmarinic Acid-Loaded Nanovesicles in Acute Colitis through Modulation of NLRP3 Inflammasome.
Ávila-Román, J; Illanes, M; Marinho, S; Motilva, V; Talero, E, 2021
)
0.91
"Rosmarinic acid is an attractive candidate for skin applications because of its antioxidant, anti-inflammatory, and photoprotective functions, however, its poor bioavailability hampers its therapeutic outcome."( Chitosan - Rosmarinic acid conjugates with antioxidant, anti-inflammatory and photoprotective properties.
Aguilar, MR; Caro-León, J; Espinosa-Cano, E; Huerta-Madroñal, M; Vázquez-Lasa, B, 2021
)
2.45
" We discuss techniques to improve RA bioavailability and provide a mechanistic discussion of RA regarding tumor prevention, treatment, and adjuvant therapy."( Rosmarinic Acid and Related Dietary Supplements: Potential Applications in the Prevention and Treatment of Cancer.
Jin, D; Tian, L; Wang, J; Wang, T; Wang, Z; Xin, Y; Xu, L; Zhao, D; Zhao, J, 2022
)
2.16

Dosage Studied

Intensive studies should be well planned to determine the dosage and toxicity level of rosmarinic acid for efficacy and safe consumption. The angiotensin-converting enzyme activity in rat lung tissue was inhibited by the ros marinic acid.

ExcerptRelevanceReference
" This quantitation method was successfully applied to a pharmacokinetic study of salvianolate administrated by intravenous infusion with dosage of 6 mg/kg in beagle dogs."( Simultaneous determination of magnesium lithospermate B, rosmarinic acid, and lithospermic acid in beagle dog serum by liquid chromatography/tandem mass spectrometry.
Jia, J; Li, X; Liu, G; Sun, W; Wang, Y; Yu, C, 2004
)
0.57
" The results demonstrated that RA is non-competitive POP inhibitor and that acute and subchronic RA treatments showed an inverted U-shaped dose-response curve in the platform crossings."( Subchronic administration of rosmarinic acid, a natural prolyl oligopeptidase inhibitor, enhances cognitive performances.
Jung, WY; Kim, JM; Park, DH; Park, SJ; Ryu, JH, 2010
)
0.65
" The extraction dosage was 1:50 (w/v)."( Rosmarinic acid from eelgrass shows nematicidal and antibacterial activities against pine wood nematode and its carrying bacteria.
Guo, D; Guo, Q; Han, Y; Li, R; Pan, X; Wang, J, 2012
)
1.82
"To establish a method for the determination of astilbin, peoniflorin, rasmarinci acid, isofraxidin and liquiritin contained in Shaolin Xiaoyin tablets, in order to lay a foundation for designing late-stage dosage forms and clinical medication schemes."( [Pharmacokinetic study on peoniflorin, astilbin, rosmarinic acid, isofraxidin and liquiritin in rat blood after oral administration of shaolin xiaoyin tablets].
Feng, LM; Lu, CJ; Wang, YJ; Zhao, RZ, 2014
)
0.66
" Administration of rosmarinic acid and extract at the dose of 25 mg/kg reduced paw oedema at 6 hr by over 60%, exhibiting a dose-response effect, suggesting that rosmarinic was the main contributor to the anti-inflammatory effect."( Anti-inflammatory effect of rosmarinic acid and an extract of Rosmarinus officinalis in rat models of local and systemic inflammation.
Barateiro, A; Brites, D; Bronze, R; Duarte, CM; Eduardo-Figueira, M; Fernandes, A; Fernandes, E; Freitas, M; Mota-Filipe, H; Pinto, R; Rocha, J; Sepodes, B; Serra, AT; Silva-Lima, B, 2015
)
1.04
" RA was administrated at a dosage of 50, 100 or 200 mg kg(-1) once a day with a normal control group and an aging control group for 30 days."( Effects of rosmarinic acid on liver and kidney antioxidant enzymes, lipid peroxidation and tissue ultrastructure in aging mice.
Chen, X; Lu, Q; Yang, L; Zhang, Y; Zu, Y, 2015
)
0.81
" These results provide a meaningful basis for developing a clinical dosage regimen in the treatment of hepatic fibrosis by FZHY."( Comparative pharmacokinetic and tissue distribution profiles of four major bioactive components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe.
Liu, CH; Liu, S; Tao, YY; Wang, CH; Yang, T; Zhou, H, 2015
)
0.42
" A dosage (25 mg/kg) was chosen to explore the neuroprotective mechanisms of salviaolate."( Salviaolate Protects Rat Brain from Ischemia-Reperfusion Injury through Inhibition of NADPH Oxidase.
Liu, B; Lou, Z; Luo, XJ; Ma, QL; Peng, J; Peng, JJ; Ren, KD; Ren, X; Tan, B; Yang, J; Yang, ZB, 2015
)
0.42
" In the presence of 50 μM of RA, dose-response for CA shifted to IC50 value of 11."( Rosmarinic acid potentiates carnosic acid induced apoptosis in lung fibroblasts.
Bahri, S; Ben Ali, R; Jameleddine, S; Mc Entee, K; Mies, F; Mlika, M; Shlyonsky, V, 2017
)
1.9
" The potential inhibitory rosmarinic acid effect on angiotensin-converting enzyme activity was compared with captopril actions by analyzing in vivo blood pressure dose-response curves to angiotensin I and bradykinin."( Effect of rosmarinic acid on the arterial blood pressure in normotensive and hypertensive rats: Role of ACE.
Albuquerque, AA; Capellini, VK; Carvalho, MTM; Celotto, AC; Evora, PRB; Ferreira, LG; Gomes, RADS; Parolini, MT, 2018
)
1.18
"(1) rosmarinic acid caused systolic blood pressure dose-dependent decrease in hypertensive rats; (2) The angiotensin I dose-response curves demonstrated that rosmarinic acid promotes minor changes in systolic blood pressure only in the hypertensive group; (3) The bradykinin dose-response curves showed that both rosmarinic acid and captopril promoted a systolic blood pressure reduction, but only the captopril effect was significant; (4) The angiotensin-converting enzyme activity in rat lung tissue was inhibited by the rosmarinic acid in a dose dependent manner; (5) The analysis of nitrite/nítrate plasma concentrations showed no significant difference among the experimental groups."( Effect of rosmarinic acid on the arterial blood pressure in normotensive and hypertensive rats: Role of ACE.
Albuquerque, AA; Capellini, VK; Carvalho, MTM; Celotto, AC; Evora, PRB; Ferreira, LG; Gomes, RADS; Parolini, MT, 2018
)
1.44
" Intensive studies should be well planned to determine the dosage and toxicity level of rosmarinic acid for efficacy and safe consumption."( Review on rosmarinic acid extraction, fractionation and its anti-diabetic potential.
Chua, LS; Lau, CH; Ngo, YL, 2018
)
1.11
" In addition, the polyphenols dose-response correlations with cellular antioxidant activity were also determined."( Antioxidant activity evaluation of rosemary ethanol extract and their cellular antioxidant activity toward HeLa cells.
Jiang, ZT; Li, R; Nie, JY; Tan, J; Tang, SH; Wang, Y, 2019
)
0.51
" To obtain a given effect, the amount of ipowder® extract to ingest will therefore be lower; a reduction in the daily dosage will be more convenient for the patient and will improve patient compliance with supplementation."( Benefits of the ipowder® extraction process applied to Melissa officinalis L.: improvement of antioxidant activity and in vitro gastro-intestinal release profile of rosmarinic acid.
Alric, M; Bardot, V; Berthomier, L; Chalancon, S; Chalard, P; Cotte, C; Denis, S; Dubourdeaux, M; Escalon, A; Leremboure, M; Ripoche, I, 2020
)
0.75
"Findings will provide timely information on the safety, efficacy, and optimal dosing of t-PA to treat moderate/severe COVID-19-induced ARDS, which can be rapidly adapted to a phase III trial (NCT04357730; FDA IND 149634)."(
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y, 2022
)
0.72
" The treatment group with a 70 mg/kg dosage decreased TGF-β1 and TNF-α levels more than the other treatment group."( Rosmarinic acid prevents post-operative abdominal adhesions in a rat model.
Ahmadvand, H; Davoodi, F; Dezfoulian, O; Kakanezhadi, A; Raisi, A; Rezaei, M, 2022
)
2.16
" In conclusion, RA loaded and combination with exosomes at a dosage of 10 mg/kg (RLE10 and R10 +E10) improved endometritis in mice through a suppressing TLR4-NLRP3 signaling pathway."( Enhanced anti-inflammatory effect of Rosmarinic acid by encapsulation and combination with the exosome in mice with LPS-induced endometritis through suppressing the TLR4-NLRP3 signaling pathway.
Asadpour, R; Fattahi, A; Jozani, RJ; Khordadmehr, M; Taravat, M, 2023
)
1.18
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (7)

RoleDescription
non-steroidal anti-inflammatory drugAn anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
serine proteinase inhibitorAn exogenous or endogenous compound which inhibits serine endopeptidases.
peripheral nervous system drugA drug that acts principally at one or more sites within the peripheral neuroeffector systems, the autonomic system, and motor nerve-skeletal system.
EC 1.1.1.21 (aldehyde reductase) inhibitorAn EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of aldehyde reductase (EC 1.1.1.21).
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
geroprotectorAny compound that supports healthy aging, slows the biological aging process, or extends lifespan.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
polyphenolMembers of the class of phenols that contain 2 or more benzene rings each of which is substituted by at least one hydroxy group.
phenylpropanoidAny organic aromatic compound with a structure based on a phenylpropane skeleton. The class includes naturally occurring phenylpropanoid esters, flavonoids, anthocyanins, coumarins and many small phenolic molecules as well as their semi-synthetic and synthetic analogues. Phenylpropanoids are also precursors of lignin.
carboxylic esterAn ester of a carboxylic acid, R(1)C(=O)OR(2), where R(1) = H or organyl and R(2) = organyl.
monocarboxylic acidAn oxoacid containing a single carboxy group.
rosmarinic acidThe 1-carboxy-2-(2,4-dihydroxyphenyl)ethyl ester of trans-caffeic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (74)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency5.62950.003245.467312,589.2998AID2517
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency4.90190.004023.8416100.0000AID485290
Chain A, Beta-lactamaseEscherichia coli K-12Potency100.00000.044717.8581100.0000AID485294
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency12.18610.140911.194039.8107AID2451
Chain A, HADH2 proteinHomo sapiens (human)Potency15.84890.025120.237639.8107AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency15.84890.025120.237639.8107AID893
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency12.58930.631035.7641100.0000AID504339
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency14.55000.177814.390939.8107AID2147
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency12.58930.125919.1169125.8920AID2549
Chain A, CruzipainTrypanosoma cruziPotency31.62280.002014.677939.8107AID1476
phosphopantetheinyl transferaseBacillus subtilisPotency67.83350.141337.9142100.0000AID1490
GLS proteinHomo sapiens (human)Potency35.48130.35487.935539.8107AID624170
Microtubule-associated protein tauHomo sapiens (human)Potency12.58930.180013.557439.8107AID1460
thioredoxin glutathione reductaseSchistosoma mansoniPotency35.48130.100022.9075100.0000AID485364
hypothetical protein, conservedTrypanosoma bruceiPotency31.62280.223911.245135.4813AID624173
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency39.81070.707936.904389.1251AID504333
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency3.54810.035520.977089.1251AID504332
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency1.99530.036619.637650.1187AID2100
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency22.38720.001815.663839.8107AID894
chromobox protein homolog 1Homo sapiens (human)Potency50.11870.006026.168889.1251AID540317
importin subunit beta-1 isoform 1Homo sapiens (human)Potency125.89205.804836.130665.1308AID540263
DNA polymerase betaHomo sapiens (human)Potency1.99530.022421.010289.1251AID485314
flap endonuclease 1Homo sapiens (human)Potency50.11870.133725.412989.1251AID588795
eyes absent homolog 2 isoform aHomo sapiens (human)Potency4.77631.199814.641950.1187AID720540
snurportin-1Homo sapiens (human)Potency125.89205.804836.130665.1308AID540263
DNA polymerase eta isoform 1Homo sapiens (human)Potency6.79020.100028.9256213.3130AID588591; AID720502
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency2.75270.050127.073689.1251AID588590; AID720496
DNA polymerase kappa isoform 1Homo sapiens (human)Potency1.49510.031622.3146100.0000AID588579
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency28.18380.00419.962528.1838AID2675
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency20.25930.251215.843239.8107AID504327
Inositol monophosphatase 1Rattus norvegicus (Norway rat)Potency19.95261.000010.475628.1838AID901
phosphoglycerate kinaseTrypanosoma brucei brucei TREU927Potency10.94720.07578.474229.0628AID602233; AID686980
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency2.81990.060110.745337.9330AID485367; AID504636; AID504637
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.37840.003245.467312,589.2998AID2517; AID2572
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency0.22390.004023.8416100.0000AID485290
Chain A, Beta-lactamaseEscherichia coli K-12Potency59.62170.044717.8581100.0000AID485294; AID485341
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency17.74070.140911.194039.8107AID2451
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency14.12540.177814.390939.8107AID2147
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency3.54810.125919.1169125.8920AID2549
endonuclease IVEscherichia coliPotency6.30960.707912.432431.6228AID2565
phosphopantetheinyl transferaseBacillus subtilisPotency50.11870.141337.9142100.0000AID1490
ATAD5 protein, partialHomo sapiens (human)Potency29.08100.004110.890331.5287AID504467
Microtubule-associated protein tauHomo sapiens (human)Potency15.18610.180013.557439.8107AID1460; AID1468
thioredoxin glutathione reductaseSchistosoma mansoniPotency3.16230.100022.9075100.0000AID485364
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency5.62340.28189.721235.4813AID2326
glucocerebrosidaseHomo sapiens (human)Potency10.00000.01268.156944.6684AID2101
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency3.54810.707936.904389.1251AID504333
Bloom syndrome protein isoform 1Homo sapiens (human)Potency22.38720.540617.639296.1227AID2528
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency2.51190.036619.637650.1187AID2100
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency34.89370.010039.53711,122.0200AID1469; AID1479
pyruvate kinase PKM isoform aHomo sapiens (human)Potency1.00000.04017.459031.6228AID1631; AID1634
DNA polymerase betaHomo sapiens (human)Potency0.22390.022421.010289.1251AID485314
ubiquitin carboxyl-terminal hydrolase 2 isoform aHomo sapiens (human)Potency25.11890.65619.452025.1189AID463254
Glutamate receptor 1Rattus norvegicus (Norway rat)Potency0.63100.01418.602439.8107AID2572
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency0.63100.001551.739315,848.9004AID2572
Glutamate receptor 3Rattus norvegicus (Norway rat)Potency0.63100.01418.602439.8107AID2572
Glutamate receptor 4Rattus norvegicus (Norway rat)Potency0.63100.01418.602439.8107AID2572
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency16.94410.060110.745337.9330AID485367
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
integrase, partialHuman immunodeficiency virus 1IC50 (µMol)3.55960.07953.52039.9390AID1053171; AID1053172
lens epithelium-derived growth factor p75Homo sapiens (human)IC50 (µMol)3.55960.07953.52039.9390AID1053171; AID1053172
rac GTPase-activating protein 1 isoform aHomo sapiens (human)IC50 (µMol)35.00007.390057.8904301.2400AID624330
AcetylcholinesteraseHomo sapiens (human)IC50 (µMol)1,220.00000.00000.933210.0000AID1802996
Mcl-1Homo sapiens (human)IC50 (µMol)2.02570.40007.134454.0000AID1417
Replicase polyprotein 1abBetacoronavirus England 1IC50 (µMol)10.00000.00403.43889.5100AID1640022
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferaseMycobacterium tuberculosis H37RvIC50 (µMol)84.94003.910083.9944180.9200AID1376
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)250.00000.03403.987110.0000AID538837
Lysine-specific histone demethylase 1AHomo sapiens (human)IC50 (µMol)20.93000.00312.16029.6000AID1845959; AID1872430
Interstitial collagenaseHomo sapiens (human)IC50 (µMol)5.60000.00020.850210.0000AID734064
Amyloid-beta precursor proteinHomo sapiens (human)IC50 (µMol)71.90000.00053.889510.0000AID1264940
Transcription factor AP-1Homo sapiens (human)IC50 (µMol)16.20000.00790.39202.0300AID1067094
Tyrosine-protein kinase LckHomo sapiens (human)IC50 (µMol)39.50000.00021.317310.0000AID224158; AID419924
Tyrosine-protein kinase FynHomo sapiens (human)IC50 (µMol)32.48330.00021.67898.6800AID280400; AID280401; AID280402; AID280403; AID280404; AID280405
Tyrosine-protein kinase FynHomo sapiens (human)Ki8.85000.01003.75507.5000AID280406; AID280407
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2IC50 (µMol)3.86000.00022.45859.9600AID1640021
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)IC50 (µMol)26.00000.00020.533510.0000AID419925
Aldo-keto reductase family 1 member B1Homo sapiens (human)IC50 (µMol)3.91000.00101.191310.0000AID477037
17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)IC50 (µMol)3.72000.09603.94009.9000AID1364654
Alpha-synucleinHomo sapiens (human)IC50 (µMol)0.21000.19003.82049.8000AID1695730
Reverse transcriptase/RNaseH Human immunodeficiency virus 1IC50 (µMol)100.00000.00011.076810.0000AID327566
Integrase Human immunodeficiency virus 1IC50 (µMol)17.21000.00051.544310.0000AID327557; AID707987; AID91425; AID93515; AID93530
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
POsterior SegregationCaenorhabditis elegansEC50 (µMol)13.60402.201047.1808186.6810AID1964
Sodium-dependent noradrenaline transporter Homo sapiens (human)EC50 (µMol)8.75100.082031.0243168.9080AID1960
Zinc finger protein mex-5Caenorhabditis elegansEC50 (µMol)8.75100.082033.5679168.9080AID1960
TransthyretinHomo sapiens (human)EC50 (µMol)8.60005.60007.54298.6000AID1169291
Amyloid-beta precursor proteinHomo sapiens (human)EC50 (µMol)48.53330.00074.20538.4100AID1264938; AID1264939; AID1500513
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (410)

Processvia Protein(s)Taxonomy
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
monoamine transportSodium-dependent noradrenaline transporter Homo sapiens (human)
neurotransmitter transportSodium-dependent noradrenaline transporter Homo sapiens (human)
chemical synaptic transmissionSodium-dependent noradrenaline transporter Homo sapiens (human)
response to xenobiotic stimulusSodium-dependent noradrenaline transporter Homo sapiens (human)
response to painSodium-dependent noradrenaline transporter Homo sapiens (human)
norepinephrine uptakeSodium-dependent noradrenaline transporter Homo sapiens (human)
neuron cellular homeostasisSodium-dependent noradrenaline transporter Homo sapiens (human)
amino acid transportSodium-dependent noradrenaline transporter Homo sapiens (human)
norepinephrine transportSodium-dependent noradrenaline transporter Homo sapiens (human)
dopamine uptake involved in synaptic transmissionSodium-dependent noradrenaline transporter Homo sapiens (human)
sodium ion transmembrane transportSodium-dependent noradrenaline transporter Homo sapiens (human)
regulation of double-strand break repair via homologous recombinationLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of protein ubiquitinationLysine-specific histone demethylase 1AHomo sapiens (human)
regulation of protein localizationLysine-specific histone demethylase 1AHomo sapiens (human)
cellular response to UVLysine-specific histone demethylase 1AHomo sapiens (human)
cellular response to gamma radiationLysine-specific histone demethylase 1AHomo sapiens (human)
DNA repair-dependent chromatin remodelingLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of transcription by RNA polymerase IILysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of neuroblast proliferationLysine-specific histone demethylase 1AHomo sapiens (human)
regulation of transcription by RNA polymerase IILysine-specific histone demethylase 1AHomo sapiens (human)
protein demethylationLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of epithelial to mesenchymal transitionLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of neuron projection developmentLysine-specific histone demethylase 1AHomo sapiens (human)
cerebral cortex developmentLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of protein bindingLysine-specific histone demethylase 1AHomo sapiens (human)
neuron maturationLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of DNA bindingLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of DNA-binding transcription factor activityLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of DNA damage response, signal transduction by p53 class mediatorLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of cell sizeLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of DNA-templated transcriptionLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of transcription by RNA polymerase IILysine-specific histone demethylase 1AHomo sapiens (human)
guanine metabolic processLysine-specific histone demethylase 1AHomo sapiens (human)
muscle cell developmentLysine-specific histone demethylase 1AHomo sapiens (human)
regulation of androgen receptor signaling pathwayLysine-specific histone demethylase 1AHomo sapiens (human)
response to fungicideLysine-specific histone demethylase 1AHomo sapiens (human)
cellular response to cAMPLysine-specific histone demethylase 1AHomo sapiens (human)
regulation of DNA methylation-dependent heterochromatin formationLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of cold-induced thermogenesisLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of neural precursor cell proliferationLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of stem cell proliferationLysine-specific histone demethylase 1AHomo sapiens (human)
chromatin remodelingLysine-specific histone demethylase 1AHomo sapiens (human)
signal transductionTransthyretinHomo sapiens (human)
purine nucleobase metabolic processTransthyretinHomo sapiens (human)
proteolysisInterstitial collagenaseHomo sapiens (human)
protein metabolic processInterstitial collagenaseHomo sapiens (human)
extracellular matrix disassemblyInterstitial collagenaseHomo sapiens (human)
collagen catabolic processInterstitial collagenaseHomo sapiens (human)
positive regulation of protein-containing complex assemblyInterstitial collagenaseHomo sapiens (human)
cellular response to UV-AInterstitial collagenaseHomo sapiens (human)
extracellular matrix organizationInterstitial collagenaseHomo sapiens (human)
regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
cognitionAmyloid-beta precursor proteinHomo sapiens (human)
G2/M transition of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
microglial cell activationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of protein phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
suckling behaviorAmyloid-beta precursor proteinHomo sapiens (human)
astrocyte activation involved in immune responseAmyloid-beta precursor proteinHomo sapiens (human)
regulation of translationAmyloid-beta precursor proteinHomo sapiens (human)
protein phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
intracellular copper ion homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
endocytosisAmyloid-beta precursor proteinHomo sapiens (human)
response to oxidative stressAmyloid-beta precursor proteinHomo sapiens (human)
cell adhesionAmyloid-beta precursor proteinHomo sapiens (human)
regulation of epidermal growth factor-activated receptor activityAmyloid-beta precursor proteinHomo sapiens (human)
Notch signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
axonogenesisAmyloid-beta precursor proteinHomo sapiens (human)
learning or memoryAmyloid-beta precursor proteinHomo sapiens (human)
learningAmyloid-beta precursor proteinHomo sapiens (human)
mating behaviorAmyloid-beta precursor proteinHomo sapiens (human)
locomotory behaviorAmyloid-beta precursor proteinHomo sapiens (human)
axo-dendritic transportAmyloid-beta precursor proteinHomo sapiens (human)
cholesterol metabolic processAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of cell population proliferationAmyloid-beta precursor proteinHomo sapiens (human)
adult locomotory behaviorAmyloid-beta precursor proteinHomo sapiens (human)
visual learningAmyloid-beta precursor proteinHomo sapiens (human)
regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of peptidyl-threonine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
microglia developmentAmyloid-beta precursor proteinHomo sapiens (human)
axon midline choice point recognitionAmyloid-beta precursor proteinHomo sapiens (human)
neuron remodelingAmyloid-beta precursor proteinHomo sapiens (human)
dendrite developmentAmyloid-beta precursor proteinHomo sapiens (human)
regulation of Wnt signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
extracellular matrix organizationAmyloid-beta precursor proteinHomo sapiens (human)
forebrain developmentAmyloid-beta precursor proteinHomo sapiens (human)
neuron projection developmentAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of chemokine productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of interleukin-1 beta productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of interleukin-6 productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of tumor necrosis factor productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
regulation of multicellular organism growthAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of neuron differentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of glycolytic processAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of JNK cascadeAmyloid-beta precursor proteinHomo sapiens (human)
astrocyte activationAmyloid-beta precursor proteinHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityAmyloid-beta precursor proteinHomo sapiens (human)
collateral sprouting in absence of injuryAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of inflammatory responseAmyloid-beta precursor proteinHomo sapiens (human)
regulation of peptidyl-tyrosine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
regulation of synapse structure or activityAmyloid-beta precursor proteinHomo sapiens (human)
synapse organizationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of calcium-mediated signalingAmyloid-beta precursor proteinHomo sapiens (human)
neuromuscular process controlling balanceAmyloid-beta precursor proteinHomo sapiens (human)
synaptic assembly at neuromuscular junctionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of protein metabolic processAmyloid-beta precursor proteinHomo sapiens (human)
neuron apoptotic processAmyloid-beta precursor proteinHomo sapiens (human)
smooth endoplasmic reticulum calcium ion homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
neuron cellular homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeAmyloid-beta precursor proteinHomo sapiens (human)
response to interleukin-1Amyloid-beta precursor proteinHomo sapiens (human)
modulation of excitatory postsynaptic potentialAmyloid-beta precursor proteinHomo sapiens (human)
NMDA selective glutamate receptor signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
regulation of spontaneous synaptic transmissionAmyloid-beta precursor proteinHomo sapiens (human)
cytosolic mRNA polyadenylationAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of long-term synaptic potentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of long-term synaptic potentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionAmyloid-beta precursor proteinHomo sapiens (human)
cellular response to amyloid-betaAmyloid-beta precursor proteinHomo sapiens (human)
regulation of presynapse assemblyAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of amyloid fibril formationAmyloid-beta precursor proteinHomo sapiens (human)
amyloid fibril formationAmyloid-beta precursor proteinHomo sapiens (human)
neuron projection maintenanceAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of T cell migrationAmyloid-beta precursor proteinHomo sapiens (human)
central nervous system developmentAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of transcription by RNA polymerase IITranscription factor AP-1Homo sapiens (human)
regulation of transcription by RNA polymerase IITranscription factor AP-1Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayTranscription factor AP-1Homo sapiens (human)
release from viral latencyTranscription factor AP-1Homo sapiens (human)
cellular response to reactive oxygen speciesTranscription factor AP-1Homo sapiens (human)
response to endoplasmic reticulum stressTranscription factor AP-1Homo sapiens (human)
positive regulation of apoptotic processTranscription factor AP-1Homo sapiens (human)
negative regulation of DNA bindingTranscription factor AP-1Homo sapiens (human)
negative regulation by host of viral transcriptionTranscription factor AP-1Homo sapiens (human)
positive regulation by host of viral transcriptionTranscription factor AP-1Homo sapiens (human)
negative regulation of DNA-templated transcriptionTranscription factor AP-1Homo sapiens (human)
positive regulation of DNA-templated transcriptionTranscription factor AP-1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IITranscription factor AP-1Homo sapiens (human)
SMAD protein signal transductionTranscription factor AP-1Homo sapiens (human)
cellular response to cadmium ionTranscription factor AP-1Homo sapiens (human)
integrated stress response signalingTranscription factor AP-1Homo sapiens (human)
positive regulation of miRNA transcriptionTranscription factor AP-1Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferationTranscription factor AP-1Homo sapiens (human)
positive regulation of DNA-templated transcription initiationTranscription factor AP-1Homo sapiens (human)
regulation of cell population proliferationTranscription factor AP-1Homo sapiens (human)
regulation of cell cycleTranscription factor AP-1Homo sapiens (human)
protein phosphorylationTyrosine-protein kinase LckHomo sapiens (human)
intracellular zinc ion homeostasisTyrosine-protein kinase LckHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processTyrosine-protein kinase LckHomo sapiens (human)
response to xenobiotic stimulusTyrosine-protein kinase LckHomo sapiens (human)
peptidyl-tyrosine phosphorylationTyrosine-protein kinase LckHomo sapiens (human)
hemopoiesisTyrosine-protein kinase LckHomo sapiens (human)
platelet activationTyrosine-protein kinase LckHomo sapiens (human)
T cell differentiationTyrosine-protein kinase LckHomo sapiens (human)
T cell costimulationTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of heterotypic cell-cell adhesionTyrosine-protein kinase LckHomo sapiens (human)
intracellular signal transductionTyrosine-protein kinase LckHomo sapiens (human)
peptidyl-tyrosine autophosphorylationTyrosine-protein kinase LckHomo sapiens (human)
Fc-gamma receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
T cell receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of T cell receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of T cell activationTyrosine-protein kinase LckHomo sapiens (human)
leukocyte migrationTyrosine-protein kinase LckHomo sapiens (human)
release of sequestered calcium ion into cytosolTyrosine-protein kinase LckHomo sapiens (human)
regulation of lymphocyte activationTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of leukocyte cell-cell adhesionTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
innate immune responseTyrosine-protein kinase LckHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
B cell receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
response to singlet oxygenTyrosine-protein kinase FynHomo sapiens (human)
neuron migrationTyrosine-protein kinase FynHomo sapiens (human)
stimulatory C-type lectin receptor signaling pathwayTyrosine-protein kinase FynHomo sapiens (human)
adaptive immune responseTyrosine-protein kinase FynHomo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusTyrosine-protein kinase FynHomo sapiens (human)
heart processTyrosine-protein kinase FynHomo sapiens (human)
protein phosphorylationTyrosine-protein kinase FynHomo sapiens (human)
calcium ion transportTyrosine-protein kinase FynHomo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayTyrosine-protein kinase FynHomo sapiens (human)
axon guidanceTyrosine-protein kinase FynHomo sapiens (human)
learningTyrosine-protein kinase FynHomo sapiens (human)
feeding behaviorTyrosine-protein kinase FynHomo sapiens (human)
regulation of cell shapeTyrosine-protein kinase FynHomo sapiens (human)
gene expressionTyrosine-protein kinase FynHomo sapiens (human)
negative regulation of gene expressionTyrosine-protein kinase FynHomo sapiens (human)
negative regulation of hydrogen peroxide biosynthetic processTyrosine-protein kinase FynHomo sapiens (human)
positive regulation of neuron projection developmentTyrosine-protein kinase FynHomo sapiens (human)
protein ubiquitinationTyrosine-protein kinase FynHomo sapiens (human)
peptidyl-tyrosine phosphorylationTyrosine-protein kinase FynHomo sapiens (human)
protein catabolic processTyrosine-protein kinase FynHomo sapiens (human)
forebrain developmentTyrosine-protein kinase FynHomo sapiens (human)
T cell costimulationTyrosine-protein kinase FynHomo sapiens (human)
negative regulation of protein ubiquitinationTyrosine-protein kinase FynHomo sapiens (human)
intracellular signal transductionTyrosine-protein kinase FynHomo sapiens (human)
cellular response to platelet-derived growth factor stimulusTyrosine-protein kinase FynHomo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosisTyrosine-protein kinase FynHomo sapiens (human)
negative regulation of protein catabolic processTyrosine-protein kinase FynHomo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT proteinTyrosine-protein kinase FynHomo sapiens (human)
response to ethanolTyrosine-protein kinase FynHomo sapiens (human)
vascular endothelial growth factor receptor signaling pathwayTyrosine-protein kinase FynHomo sapiens (human)
ephrin receptor signaling pathwayTyrosine-protein kinase FynHomo sapiens (human)
dendrite morphogenesisTyrosine-protein kinase FynHomo sapiens (human)
regulation of peptidyl-tyrosine phosphorylationTyrosine-protein kinase FynHomo sapiens (human)
activated T cell proliferationTyrosine-protein kinase FynHomo sapiens (human)
modulation of chemical synaptic transmissionTyrosine-protein kinase FynHomo sapiens (human)
T cell receptor signaling pathwayTyrosine-protein kinase FynHomo sapiens (human)
leukocyte migrationTyrosine-protein kinase FynHomo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTyrosine-protein kinase FynHomo sapiens (human)
cellular response to hydrogen peroxideTyrosine-protein kinase FynHomo sapiens (human)
cellular response to transforming growth factor beta stimulusTyrosine-protein kinase FynHomo sapiens (human)
positive regulation of protein targeting to membraneTyrosine-protein kinase FynHomo sapiens (human)
dendritic spine maintenanceTyrosine-protein kinase FynHomo sapiens (human)
positive regulation of protein localization to nucleusTyrosine-protein kinase FynHomo sapiens (human)
regulation of glutamate receptor signaling pathwayTyrosine-protein kinase FynHomo sapiens (human)
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein kinase FynHomo sapiens (human)
negative regulation of dendritic spine maintenanceTyrosine-protein kinase FynHomo sapiens (human)
response to amyloid-betaTyrosine-protein kinase FynHomo sapiens (human)
cellular response to amyloid-betaTyrosine-protein kinase FynHomo sapiens (human)
cellular response to L-glutamateTyrosine-protein kinase FynHomo sapiens (human)
cellular response to glycineTyrosine-protein kinase FynHomo sapiens (human)
positive regulation of protein localization to membraneTyrosine-protein kinase FynHomo sapiens (human)
regulation of calcium ion import across plasma membraneTyrosine-protein kinase FynHomo sapiens (human)
positive regulation of cysteine-type endopeptidase activityTyrosine-protein kinase FynHomo sapiens (human)
innate immune responseTyrosine-protein kinase FynHomo sapiens (human)
cell differentiationTyrosine-protein kinase FynHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayTyrosine-protein kinase FynHomo sapiens (human)
peptidyl-tyrosine phosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
primary ovarian follicle growthProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of cytokine productionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
stimulatory C-type lectin receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
signal transductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
signal complex assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
epidermal growth factor receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
transforming growth factor beta receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
integrin-mediated signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
spermatogenesisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
learning or memoryProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to xenobiotic stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to mechanical stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to acidic pHProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of gene expressionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of epithelial cell migrationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of epithelial cell migrationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of glucose metabolic processProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of protein processingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
skeletal muscle cell proliferationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of smooth muscle cell migrationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
macroautophagyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
peptidyl-tyrosine phosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of cell-cell adhesionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
platelet activationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
forebrain developmentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
T cell costimulationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of protein-containing complex assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein destabilizationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to nutrient levelsProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of telomere maintenance via telomeraseProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to insulin stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of intracellular estrogen receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of integrin activationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of toll-like receptor 3 signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
adherens junction organizationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
substrate adhesion-dependent cell spreadingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of dephosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of hippo signalingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
intracellular signal transductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
entry of bacterium into host cellProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
osteoclast developmentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to platelet-derived growth factor stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ERBB2 signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
angiotensin-activated signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
odontogenesisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of apoptotic processProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of apoptotic processProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of vascular permeabilityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
stress fiber assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
transcytosisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of bone resorptionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
bone resorptionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of Notch signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of bone resorptionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of Ras protein signal transductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of insulin receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein autophosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
platelet-derived growth factor receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
vascular endothelial growth factor receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
neurotrophin TRK receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ephrin receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
focal adhesion assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
oogenesisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
progesterone receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
leukocyte migrationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of small GTPase mediated signal transductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of protein transportProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to mineralocorticoidProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
myoblast proliferationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to electrical stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of focal adhesion assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of mitochondrial depolarizationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of telomerase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
uterus developmentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
branching involved in mammary gland duct morphogenesisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of cell projection assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
intestinal epithelial cell developmentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
interleukin-6-mediated signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to hydrogen peroxideProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to interleukin-1Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to lipopolysaccharideProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to peptide hormone stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to progesterone stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to fatty acidProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to hypoxiaProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to fluid shear stressProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of podosome assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
DNA biosynthetic processProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of protein serine/threonine kinase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of heart rate by cardiac conductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of canonical Wnt signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cell-cell adhesionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of protein localization to nucleusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of non-membrane spanning protein tyrosine kinase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of TORC1 signalingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to prolactinProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of male germ cell proliferationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of ovarian follicle developmentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of lamellipodium morphogenesisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of platelet-derived growth factor receptor-beta signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of early endosome to late endosome transportProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of anoikisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of caveolin-mediated endocytosisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cell differentiationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cell adhesionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
innate immune responseProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein phosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
symbiont entry into host cellProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
epithelial cell maturationAldo-keto reductase family 1 member B1Homo sapiens (human)
renal water homeostasisAldo-keto reductase family 1 member B1Homo sapiens (human)
carbohydrate metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
C21-steroid hormone biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
L-ascorbic acid biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
regulation of urine volumeAldo-keto reductase family 1 member B1Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of apoptotic processAldo-keto reductase family 1 member B1Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
fructose biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
cellular hyperosmotic salinity responseAldo-keto reductase family 1 member B1Homo sapiens (human)
metanephric collecting duct developmentAldo-keto reductase family 1 member B1Homo sapiens (human)
in utero embryonic development17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
placenta development17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
estrogen biosynthetic process17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
androgen metabolic process17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
response to retinoic acid17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
steroid metabolic process17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
calcium ion homeostasisAlpha-synucleinHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIAlpha-synucleinHomo sapiens (human)
microglial cell activationAlpha-synucleinHomo sapiens (human)
positive regulation of receptor recyclingAlpha-synucleinHomo sapiens (human)
positive regulation of neurotransmitter secretionAlpha-synucleinHomo sapiens (human)
negative regulation of protein kinase activityAlpha-synucleinHomo sapiens (human)
fatty acid metabolic processAlpha-synucleinHomo sapiens (human)
neutral lipid metabolic processAlpha-synucleinHomo sapiens (human)
phospholipid metabolic processAlpha-synucleinHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
mitochondrial membrane organizationAlpha-synucleinHomo sapiens (human)
adult locomotory behaviorAlpha-synucleinHomo sapiens (human)
response to xenobiotic stimulusAlpha-synucleinHomo sapiens (human)
response to iron(II) ionAlpha-synucleinHomo sapiens (human)
regulation of phospholipase activityAlpha-synucleinHomo sapiens (human)
negative regulation of platelet-derived growth factor receptor signaling pathwayAlpha-synucleinHomo sapiens (human)
regulation of glutamate secretionAlpha-synucleinHomo sapiens (human)
regulation of dopamine secretionAlpha-synucleinHomo sapiens (human)
synaptic vesicle exocytosisAlpha-synucleinHomo sapiens (human)
synaptic vesicle primingAlpha-synucleinHomo sapiens (human)
regulation of transmembrane transporter activityAlpha-synucleinHomo sapiens (human)
negative regulation of microtubule polymerizationAlpha-synucleinHomo sapiens (human)
receptor internalizationAlpha-synucleinHomo sapiens (human)
protein destabilizationAlpha-synucleinHomo sapiens (human)
response to magnesium ionAlpha-synucleinHomo sapiens (human)
negative regulation of transporter activityAlpha-synucleinHomo sapiens (human)
response to lipopolysaccharideAlpha-synucleinHomo sapiens (human)
negative regulation of monooxygenase activityAlpha-synucleinHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationAlpha-synucleinHomo sapiens (human)
response to type II interferonAlpha-synucleinHomo sapiens (human)
cellular response to oxidative stressAlpha-synucleinHomo sapiens (human)
SNARE complex assemblyAlpha-synucleinHomo sapiens (human)
positive regulation of SNARE complex assemblyAlpha-synucleinHomo sapiens (human)
regulation of locomotionAlpha-synucleinHomo sapiens (human)
dopamine biosynthetic processAlpha-synucleinHomo sapiens (human)
mitochondrial ATP synthesis coupled electron transportAlpha-synucleinHomo sapiens (human)
regulation of macrophage activationAlpha-synucleinHomo sapiens (human)
positive regulation of apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of neuron apoptotic processAlpha-synucleinHomo sapiens (human)
positive regulation of endocytosisAlpha-synucleinHomo sapiens (human)
negative regulation of exocytosisAlpha-synucleinHomo sapiens (human)
positive regulation of exocytosisAlpha-synucleinHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityAlpha-synucleinHomo sapiens (human)
synaptic vesicle endocytosisAlpha-synucleinHomo sapiens (human)
synaptic vesicle transportAlpha-synucleinHomo sapiens (human)
positive regulation of inflammatory responseAlpha-synucleinHomo sapiens (human)
regulation of acyl-CoA biosynthetic processAlpha-synucleinHomo sapiens (human)
protein tetramerizationAlpha-synucleinHomo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolAlpha-synucleinHomo sapiens (human)
neuron apoptotic processAlpha-synucleinHomo sapiens (human)
dopamine uptake involved in synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of dopamine uptake involved in synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of serotonin uptakeAlpha-synucleinHomo sapiens (human)
regulation of norepinephrine uptakeAlpha-synucleinHomo sapiens (human)
negative regulation of norepinephrine uptakeAlpha-synucleinHomo sapiens (human)
excitatory postsynaptic potentialAlpha-synucleinHomo sapiens (human)
long-term synaptic potentiationAlpha-synucleinHomo sapiens (human)
positive regulation of inositol phosphate biosynthetic processAlpha-synucleinHomo sapiens (human)
negative regulation of thrombin-activated receptor signaling pathwayAlpha-synucleinHomo sapiens (human)
response to interleukin-1Alpha-synucleinHomo sapiens (human)
cellular response to copper ionAlpha-synucleinHomo sapiens (human)
cellular response to epinephrine stimulusAlpha-synucleinHomo sapiens (human)
positive regulation of protein serine/threonine kinase activityAlpha-synucleinHomo sapiens (human)
supramolecular fiber organizationAlpha-synucleinHomo sapiens (human)
negative regulation of mitochondrial electron transport, NADH to ubiquinoneAlpha-synucleinHomo sapiens (human)
positive regulation of glutathione peroxidase activityAlpha-synucleinHomo sapiens (human)
positive regulation of hydrogen peroxide catabolic processAlpha-synucleinHomo sapiens (human)
regulation of synaptic vesicle recyclingAlpha-synucleinHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processAlpha-synucleinHomo sapiens (human)
positive regulation of protein localization to cell peripheryAlpha-synucleinHomo sapiens (human)
negative regulation of chaperone-mediated autophagyAlpha-synucleinHomo sapiens (human)
regulation of presynapse assemblyAlpha-synucleinHomo sapiens (human)
amyloid fibril formationAlpha-synucleinHomo sapiens (human)
synapse organizationAlpha-synucleinHomo sapiens (human)
chemical synaptic transmissionAlpha-synucleinHomo sapiens (human)
response to reactive oxygen speciesHyaluronidase-1Homo sapiens (human)
carbohydrate metabolic processHyaluronidase-1Homo sapiens (human)
glycosaminoglycan catabolic processHyaluronidase-1Homo sapiens (human)
inflammatory responseHyaluronidase-1Homo sapiens (human)
response to virusHyaluronidase-1Homo sapiens (human)
positive regulation of epithelial cell migrationHyaluronidase-1Homo sapiens (human)
chondroitin sulfate catabolic processHyaluronidase-1Homo sapiens (human)
hyaluronan metabolic processHyaluronidase-1Homo sapiens (human)
hyaluronan biosynthetic processHyaluronidase-1Homo sapiens (human)
hyaluronan catabolic processHyaluronidase-1Homo sapiens (human)
positive regulation of cell growthHyaluronidase-1Homo sapiens (human)
negative regulation of cell growthHyaluronidase-1Homo sapiens (human)
cellular response to platelet-derived growth factor stimulusHyaluronidase-1Homo sapiens (human)
cellular response to fibroblast growth factor stimulusHyaluronidase-1Homo sapiens (human)
positive regulation of angiogenesisHyaluronidase-1Homo sapiens (human)
positive regulation of cell adhesionHyaluronidase-1Homo sapiens (human)
positive regulation of growthHyaluronidase-1Homo sapiens (human)
response to antibioticHyaluronidase-1Homo sapiens (human)
positive regulation of epithelial cell proliferationHyaluronidase-1Homo sapiens (human)
cartilage developmentHyaluronidase-1Homo sapiens (human)
embryonic skeletal joint morphogenesisHyaluronidase-1Homo sapiens (human)
cellular response to interleukin-1Hyaluronidase-1Homo sapiens (human)
cellular response to tumor necrosis factorHyaluronidase-1Homo sapiens (human)
cellular response to pHHyaluronidase-1Homo sapiens (human)
cellular response to UV-BHyaluronidase-1Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleHyaluronidase-1Homo sapiens (human)
positive regulation of hyaluranon cable assemblyHyaluronidase-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (146)

Processvia Protein(s)Taxonomy
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
actin bindingSodium-dependent noradrenaline transporter Homo sapiens (human)
neurotransmitter transmembrane transporter activitySodium-dependent noradrenaline transporter Homo sapiens (human)
neurotransmitter:sodium symporter activitySodium-dependent noradrenaline transporter Homo sapiens (human)
dopamine:sodium symporter activitySodium-dependent noradrenaline transporter Homo sapiens (human)
norepinephrine:sodium symporter activitySodium-dependent noradrenaline transporter Homo sapiens (human)
protein bindingSodium-dependent noradrenaline transporter Homo sapiens (human)
monoamine transmembrane transporter activitySodium-dependent noradrenaline transporter Homo sapiens (human)
alpha-tubulin bindingSodium-dependent noradrenaline transporter Homo sapiens (human)
metal ion bindingSodium-dependent noradrenaline transporter Homo sapiens (human)
beta-tubulin bindingSodium-dependent noradrenaline transporter Homo sapiens (human)
telomeric DNA bindingLysine-specific histone demethylase 1AHomo sapiens (human)
p53 bindingLysine-specific histone demethylase 1AHomo sapiens (human)
chromatin bindingLysine-specific histone demethylase 1AHomo sapiens (human)
transcription coactivator activityLysine-specific histone demethylase 1AHomo sapiens (human)
protein bindingLysine-specific histone demethylase 1AHomo sapiens (human)
oxidoreductase activityLysine-specific histone demethylase 1AHomo sapiens (human)
enzyme bindingLysine-specific histone demethylase 1AHomo sapiens (human)
nuclear receptor coactivator activityLysine-specific histone demethylase 1AHomo sapiens (human)
demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
histone demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
histone H3K4 demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
histone H3K9 demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
identical protein bindingLysine-specific histone demethylase 1AHomo sapiens (human)
MRF bindingLysine-specific histone demethylase 1AHomo sapiens (human)
flavin adenine dinucleotide bindingLysine-specific histone demethylase 1AHomo sapiens (human)
nuclear androgen receptor bindingLysine-specific histone demethylase 1AHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingLysine-specific histone demethylase 1AHomo sapiens (human)
telomeric repeat-containing RNA bindingLysine-specific histone demethylase 1AHomo sapiens (human)
DNA-binding transcription factor bindingLysine-specific histone demethylase 1AHomo sapiens (human)
FAD-dependent H3K4me/H3K4me3 demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
promoter-specific chromatin bindingLysine-specific histone demethylase 1AHomo sapiens (human)
transcription factor bindingLysine-specific histone demethylase 1AHomo sapiens (human)
hormone activityTransthyretinHomo sapiens (human)
protein bindingTransthyretinHomo sapiens (human)
identical protein bindingTransthyretinHomo sapiens (human)
thyroid hormone bindingTransthyretinHomo sapiens (human)
endopeptidase activityInterstitial collagenaseHomo sapiens (human)
metalloendopeptidase activityInterstitial collagenaseHomo sapiens (human)
serine-type endopeptidase activityInterstitial collagenaseHomo sapiens (human)
peptidase activityInterstitial collagenaseHomo sapiens (human)
zinc ion bindingInterstitial collagenaseHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingAmyloid-beta precursor proteinHomo sapiens (human)
DNA bindingAmyloid-beta precursor proteinHomo sapiens (human)
serine-type endopeptidase inhibitor activityAmyloid-beta precursor proteinHomo sapiens (human)
signaling receptor bindingAmyloid-beta precursor proteinHomo sapiens (human)
protein bindingAmyloid-beta precursor proteinHomo sapiens (human)
heparin bindingAmyloid-beta precursor proteinHomo sapiens (human)
enzyme bindingAmyloid-beta precursor proteinHomo sapiens (human)
identical protein bindingAmyloid-beta precursor proteinHomo sapiens (human)
transition metal ion bindingAmyloid-beta precursor proteinHomo sapiens (human)
receptor ligand activityAmyloid-beta precursor proteinHomo sapiens (human)
PTB domain bindingAmyloid-beta precursor proteinHomo sapiens (human)
protein serine/threonine kinase bindingAmyloid-beta precursor proteinHomo sapiens (human)
signaling receptor activator activityAmyloid-beta precursor proteinHomo sapiens (human)
transcription cis-regulatory region bindingTranscription factor AP-1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTranscription factor AP-1Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificTranscription factor AP-1Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificTranscription factor AP-1Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificTranscription factor AP-1Homo sapiens (human)
DNA bindingTranscription factor AP-1Homo sapiens (human)
DNA-binding transcription factor activityTranscription factor AP-1Homo sapiens (human)
RNA bindingTranscription factor AP-1Homo sapiens (human)
GTPase activator activityTranscription factor AP-1Homo sapiens (human)
protein bindingTranscription factor AP-1Homo sapiens (human)
enzyme bindingTranscription factor AP-1Homo sapiens (human)
ubiquitin protein ligase bindingTranscription factor AP-1Homo sapiens (human)
cAMP response element bindingTranscription factor AP-1Homo sapiens (human)
identical protein bindingTranscription factor AP-1Homo sapiens (human)
ubiquitin-like protein ligase bindingTranscription factor AP-1Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingTranscription factor AP-1Homo sapiens (human)
R-SMAD bindingTranscription factor AP-1Homo sapiens (human)
general transcription initiation factor bindingTranscription factor AP-1Homo sapiens (human)
sequence-specific double-stranded DNA bindingTranscription factor AP-1Homo sapiens (human)
transcription factor bindingTranscription factor AP-1Homo sapiens (human)
phosphotyrosine residue bindingTyrosine-protein kinase LckHomo sapiens (human)
protein tyrosine kinase activityTyrosine-protein kinase LckHomo sapiens (human)
non-membrane spanning protein tyrosine kinase activityTyrosine-protein kinase LckHomo sapiens (human)
protein serine/threonine phosphatase activityTyrosine-protein kinase LckHomo sapiens (human)
protein bindingTyrosine-protein kinase LckHomo sapiens (human)
ATP bindingTyrosine-protein kinase LckHomo sapiens (human)
phospholipase activator activityTyrosine-protein kinase LckHomo sapiens (human)
protein kinase bindingTyrosine-protein kinase LckHomo sapiens (human)
protein phosphatase bindingTyrosine-protein kinase LckHomo sapiens (human)
SH2 domain bindingTyrosine-protein kinase LckHomo sapiens (human)
T cell receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
CD4 receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
CD8 receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
identical protein bindingTyrosine-protein kinase LckHomo sapiens (human)
phospholipase bindingTyrosine-protein kinase LckHomo sapiens (human)
phosphatidylinositol 3-kinase bindingTyrosine-protein kinase LckHomo sapiens (human)
ATPase bindingTyrosine-protein kinase LckHomo sapiens (human)
signaling receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
protein tyrosine kinase activityTyrosine-protein kinase FynHomo sapiens (human)
non-membrane spanning protein tyrosine kinase activityTyrosine-protein kinase FynHomo sapiens (human)
protein bindingTyrosine-protein kinase FynHomo sapiens (human)
ATP bindingTyrosine-protein kinase FynHomo sapiens (human)
phospholipase activator activityTyrosine-protein kinase FynHomo sapiens (human)
enzyme bindingTyrosine-protein kinase FynHomo sapiens (human)
type 5 metabotropic glutamate receptor bindingTyrosine-protein kinase FynHomo sapiens (human)
identical protein bindingTyrosine-protein kinase FynHomo sapiens (human)
alpha-tubulin bindingTyrosine-protein kinase FynHomo sapiens (human)
phospholipase bindingTyrosine-protein kinase FynHomo sapiens (human)
transmembrane transporter bindingTyrosine-protein kinase FynHomo sapiens (human)
metal ion bindingTyrosine-protein kinase FynHomo sapiens (human)
ephrin receptor bindingTyrosine-protein kinase FynHomo sapiens (human)
tau protein bindingTyrosine-protein kinase FynHomo sapiens (human)
tau-protein kinase activityTyrosine-protein kinase FynHomo sapiens (human)
growth factor receptor bindingTyrosine-protein kinase FynHomo sapiens (human)
scaffold protein bindingTyrosine-protein kinase FynHomo sapiens (human)
disordered domain specific bindingTyrosine-protein kinase FynHomo sapiens (human)
signaling receptor bindingTyrosine-protein kinase FynHomo sapiens (human)
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA endonuclease activity, producing 3'-phosphomonoestersReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
ISG15-specific peptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein kinase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein tyrosine kinase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
non-membrane spanning protein tyrosine kinase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein kinase C bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
signaling receptor bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
insulin receptor bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
integrin bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ATP bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
phospholipase activator activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
enzyme bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
heme bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
nuclear estrogen receptor bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
SH2 domain bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
phospholipase bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
transmembrane transporter bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cadherin bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ephrin receptor bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ATPase bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
phosphoprotein bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
BMP receptor bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
connexin bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
scaffold protein bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B1Homo sapiens (human)
electron transfer activityAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glyceraldehyde oxidoreductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
L-glucuronate reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glycerol dehydrogenase [NADP+] activityAldo-keto reductase family 1 member B1Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
estradiol 17-beta-dehydrogenase [NAD(P)] activity17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
testosterone dehydrogenase (NAD+) activity17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
fatty acid bindingAlpha-synucleinHomo sapiens (human)
phospholipase D inhibitor activityAlpha-synucleinHomo sapiens (human)
SNARE bindingAlpha-synucleinHomo sapiens (human)
magnesium ion bindingAlpha-synucleinHomo sapiens (human)
transcription cis-regulatory region bindingAlpha-synucleinHomo sapiens (human)
actin bindingAlpha-synucleinHomo sapiens (human)
protein kinase inhibitor activityAlpha-synucleinHomo sapiens (human)
copper ion bindingAlpha-synucleinHomo sapiens (human)
calcium ion bindingAlpha-synucleinHomo sapiens (human)
protein bindingAlpha-synucleinHomo sapiens (human)
phospholipid bindingAlpha-synucleinHomo sapiens (human)
ferrous iron bindingAlpha-synucleinHomo sapiens (human)
zinc ion bindingAlpha-synucleinHomo sapiens (human)
lipid bindingAlpha-synucleinHomo sapiens (human)
oxidoreductase activityAlpha-synucleinHomo sapiens (human)
kinesin bindingAlpha-synucleinHomo sapiens (human)
Hsp70 protein bindingAlpha-synucleinHomo sapiens (human)
histone bindingAlpha-synucleinHomo sapiens (human)
identical protein bindingAlpha-synucleinHomo sapiens (human)
alpha-tubulin bindingAlpha-synucleinHomo sapiens (human)
cysteine-type endopeptidase inhibitor activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
tau protein bindingAlpha-synucleinHomo sapiens (human)
phosphoprotein bindingAlpha-synucleinHomo sapiens (human)
molecular adaptor activityAlpha-synucleinHomo sapiens (human)
dynein complex bindingAlpha-synucleinHomo sapiens (human)
cuprous ion bindingAlpha-synucleinHomo sapiens (human)
virus receptor activityHyaluronidase-1Homo sapiens (human)
hyalurononglucosaminidase activityHyaluronidase-1Homo sapiens (human)
hyaluronan synthase activityHyaluronidase-1Homo sapiens (human)
chondroitin hydrolase activityHyaluronidase-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (95)

Processvia Protein(s)Taxonomy
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
plasma membraneSodium-dependent noradrenaline transporter Homo sapiens (human)
cell surfaceSodium-dependent noradrenaline transporter Homo sapiens (human)
membraneSodium-dependent noradrenaline transporter Homo sapiens (human)
neuronal cell body membraneSodium-dependent noradrenaline transporter Homo sapiens (human)
presynaptic membraneSodium-dependent noradrenaline transporter Homo sapiens (human)
plasma membraneSodium-dependent noradrenaline transporter Homo sapiens (human)
axonSodium-dependent noradrenaline transporter Homo sapiens (human)
chromatinLysine-specific histone demethylase 1AHomo sapiens (human)
nucleusLysine-specific histone demethylase 1AHomo sapiens (human)
chromosome, telomeric regionLysine-specific histone demethylase 1AHomo sapiens (human)
nucleusLysine-specific histone demethylase 1AHomo sapiens (human)
nucleoplasmLysine-specific histone demethylase 1AHomo sapiens (human)
transcription regulator complexLysine-specific histone demethylase 1AHomo sapiens (human)
protein-containing complexLysine-specific histone demethylase 1AHomo sapiens (human)
DNA repair complexLysine-specific histone demethylase 1AHomo sapiens (human)
extracellular regionTransthyretinHomo sapiens (human)
extracellular spaceTransthyretinHomo sapiens (human)
azurophil granule lumenTransthyretinHomo sapiens (human)
extracellular exosomeTransthyretinHomo sapiens (human)
extracellular spaceTransthyretinHomo sapiens (human)
extracellular regionInterstitial collagenaseHomo sapiens (human)
extracellular matrixInterstitial collagenaseHomo sapiens (human)
extracellular spaceInterstitial collagenaseHomo sapiens (human)
extracellular spaceAmyloid-beta precursor proteinHomo sapiens (human)
dendriteAmyloid-beta precursor proteinHomo sapiens (human)
extracellular regionAmyloid-beta precursor proteinHomo sapiens (human)
extracellular spaceAmyloid-beta precursor proteinHomo sapiens (human)
nuclear envelope lumenAmyloid-beta precursor proteinHomo sapiens (human)
cytoplasmAmyloid-beta precursor proteinHomo sapiens (human)
mitochondrial inner membraneAmyloid-beta precursor proteinHomo sapiens (human)
endosomeAmyloid-beta precursor proteinHomo sapiens (human)
early endosomeAmyloid-beta precursor proteinHomo sapiens (human)
endoplasmic reticulumAmyloid-beta precursor proteinHomo sapiens (human)
endoplasmic reticulum lumenAmyloid-beta precursor proteinHomo sapiens (human)
smooth endoplasmic reticulumAmyloid-beta precursor proteinHomo sapiens (human)
Golgi apparatusAmyloid-beta precursor proteinHomo sapiens (human)
Golgi lumenAmyloid-beta precursor proteinHomo sapiens (human)
Golgi-associated vesicleAmyloid-beta precursor proteinHomo sapiens (human)
cytosolAmyloid-beta precursor proteinHomo sapiens (human)
plasma membraneAmyloid-beta precursor proteinHomo sapiens (human)
clathrin-coated pitAmyloid-beta precursor proteinHomo sapiens (human)
cell-cell junctionAmyloid-beta precursor proteinHomo sapiens (human)
synaptic vesicleAmyloid-beta precursor proteinHomo sapiens (human)
cell surfaceAmyloid-beta precursor proteinHomo sapiens (human)
membraneAmyloid-beta precursor proteinHomo sapiens (human)
COPII-coated ER to Golgi transport vesicleAmyloid-beta precursor proteinHomo sapiens (human)
axonAmyloid-beta precursor proteinHomo sapiens (human)
growth coneAmyloid-beta precursor proteinHomo sapiens (human)
platelet alpha granule lumenAmyloid-beta precursor proteinHomo sapiens (human)
neuromuscular junctionAmyloid-beta precursor proteinHomo sapiens (human)
endosome lumenAmyloid-beta precursor proteinHomo sapiens (human)
trans-Golgi network membraneAmyloid-beta precursor proteinHomo sapiens (human)
ciliary rootletAmyloid-beta precursor proteinHomo sapiens (human)
dendritic spineAmyloid-beta precursor proteinHomo sapiens (human)
dendritic shaftAmyloid-beta precursor proteinHomo sapiens (human)
perikaryonAmyloid-beta precursor proteinHomo sapiens (human)
membrane raftAmyloid-beta precursor proteinHomo sapiens (human)
apical part of cellAmyloid-beta precursor proteinHomo sapiens (human)
synapseAmyloid-beta precursor proteinHomo sapiens (human)
perinuclear region of cytoplasmAmyloid-beta precursor proteinHomo sapiens (human)
presynaptic active zoneAmyloid-beta precursor proteinHomo sapiens (human)
spindle midzoneAmyloid-beta precursor proteinHomo sapiens (human)
recycling endosomeAmyloid-beta precursor proteinHomo sapiens (human)
extracellular exosomeAmyloid-beta precursor proteinHomo sapiens (human)
receptor complexAmyloid-beta precursor proteinHomo sapiens (human)
early endosomeAmyloid-beta precursor proteinHomo sapiens (human)
membrane raftAmyloid-beta precursor proteinHomo sapiens (human)
cell surfaceAmyloid-beta precursor proteinHomo sapiens (human)
Golgi apparatusAmyloid-beta precursor proteinHomo sapiens (human)
plasma membraneAmyloid-beta precursor proteinHomo sapiens (human)
nuclear chromosomeTranscription factor AP-1Homo sapiens (human)
nucleusTranscription factor AP-1Homo sapiens (human)
nucleoplasmTranscription factor AP-1Homo sapiens (human)
transcription factor AP-1 complexTranscription factor AP-1Homo sapiens (human)
RNA polymerase II transcription regulator complexTranscription factor AP-1Homo sapiens (human)
chromatinTranscription factor AP-1Homo sapiens (human)
euchromatinTranscription factor AP-1Homo sapiens (human)
transcription regulator complexTranscription factor AP-1Homo sapiens (human)
pericentriolar materialTyrosine-protein kinase LckHomo sapiens (human)
immunological synapseTyrosine-protein kinase LckHomo sapiens (human)
cytosolTyrosine-protein kinase LckHomo sapiens (human)
plasma membraneTyrosine-protein kinase LckHomo sapiens (human)
membrane raftTyrosine-protein kinase LckHomo sapiens (human)
extracellular exosomeTyrosine-protein kinase LckHomo sapiens (human)
plasma membraneTyrosine-protein kinase LckHomo sapiens (human)
membrane raftTyrosine-protein kinase FynHomo sapiens (human)
dendriteTyrosine-protein kinase FynHomo sapiens (human)
nucleusTyrosine-protein kinase FynHomo sapiens (human)
mitochondrionTyrosine-protein kinase FynHomo sapiens (human)
endosomeTyrosine-protein kinase FynHomo sapiens (human)
cytosolTyrosine-protein kinase FynHomo sapiens (human)
actin filamentTyrosine-protein kinase FynHomo sapiens (human)
plasma membraneTyrosine-protein kinase FynHomo sapiens (human)
postsynaptic densityTyrosine-protein kinase FynHomo sapiens (human)
dendriteTyrosine-protein kinase FynHomo sapiens (human)
perikaryonTyrosine-protein kinase FynHomo sapiens (human)
cell bodyTyrosine-protein kinase FynHomo sapiens (human)
membrane raftTyrosine-protein kinase FynHomo sapiens (human)
perinuclear region of cytoplasmTyrosine-protein kinase FynHomo sapiens (human)
perinuclear endoplasmic reticulumTyrosine-protein kinase FynHomo sapiens (human)
glial cell projectionTyrosine-protein kinase FynHomo sapiens (human)
Schaffer collateral - CA1 synapseTyrosine-protein kinase FynHomo sapiens (human)
plasma membraneTyrosine-protein kinase FynHomo sapiens (human)
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
podosomeProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
nucleoplasmProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cytoplasmProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
mitochondrionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
mitochondrial inner membraneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
lysosomeProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
late endosomeProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cytosolProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
actin filamentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
plasma membraneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
caveolaProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
focal adhesionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cell junctionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ruffle membraneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
neuronal cell bodyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
dendritic growth coneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
membrane raftProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
perinuclear region of cytoplasmProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
extracellular exosomeProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
synaptic membraneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
glutamatergic synapseProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
postsynaptic specialization, intracellular componentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
dendritic filopodiumProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
plasma membraneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
extracellular spaceAldo-keto reductase family 1 member B1Homo sapiens (human)
nucleoplasmAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
extracellular exosomeAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
plasma membraneGlutamate receptor 1Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
endoplasmic reticulum membrane17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
intracellular membrane-bounded organelle17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
platelet alpha granule membraneAlpha-synucleinHomo sapiens (human)
extracellular regionAlpha-synucleinHomo sapiens (human)
extracellular spaceAlpha-synucleinHomo sapiens (human)
nucleusAlpha-synucleinHomo sapiens (human)
cytoplasmAlpha-synucleinHomo sapiens (human)
mitochondrionAlpha-synucleinHomo sapiens (human)
lysosomeAlpha-synucleinHomo sapiens (human)
cytosolAlpha-synucleinHomo sapiens (human)
plasma membraneAlpha-synucleinHomo sapiens (human)
cell cortexAlpha-synucleinHomo sapiens (human)
actin cytoskeletonAlpha-synucleinHomo sapiens (human)
membraneAlpha-synucleinHomo sapiens (human)
inclusion bodyAlpha-synucleinHomo sapiens (human)
axonAlpha-synucleinHomo sapiens (human)
growth coneAlpha-synucleinHomo sapiens (human)
synaptic vesicle membraneAlpha-synucleinHomo sapiens (human)
perinuclear region of cytoplasmAlpha-synucleinHomo sapiens (human)
postsynapseAlpha-synucleinHomo sapiens (human)
supramolecular fiberAlpha-synucleinHomo sapiens (human)
protein-containing complexAlpha-synucleinHomo sapiens (human)
cytoplasmAlpha-synucleinHomo sapiens (human)
axon terminusAlpha-synucleinHomo sapiens (human)
neuronal cell bodyAlpha-synucleinHomo sapiens (human)
extracellular spaceHyaluronidase-1Homo sapiens (human)
cytoplasmHyaluronidase-1Homo sapiens (human)
lysosomeHyaluronidase-1Homo sapiens (human)
cytoplasmic vesicleHyaluronidase-1Homo sapiens (human)
hyaluranon cableHyaluronidase-1Homo sapiens (human)
lysosomal lumenHyaluronidase-1Homo sapiens (human)
extracellular exosomeHyaluronidase-1Homo sapiens (human)
cytoplasmic vesicleHyaluronidase-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (306)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1802996AChE Inhibition Bioassay from Article 10.3109/14756366.2010.529806: \\Bifunctional phenolic-choline conjugates as anti-oxidants and acetylcholinesterase inhibitors.\\2011Journal of enzyme inhibition and medicinal chemistry, Aug, Volume: 26, Issue:4
Bifunctional phenolic-choline conjugates as anti-oxidants and acetylcholinesterase inhibitors.
AID1374877Potentiation of meropenem-induced antimicrobial activity against Escherichia coli BL21(DE3) assessed as meropenem MIC at 50 uM measured after 16 to 20 hrs by microdilution broth method (Rvb = <0.125 mg/L)2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID1374863Competitive inhibition of bacterial N-terminal His6-tagged VIM2 (27 to 266 residues) expressed in Escherichia coli BL21 DE3 pLysS cells using varying levels of FC-5 as substrate by fluorescence assay2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID403343Inhibition of COX2 at 1000 uM2005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID1615749Hepatoprotective activity against H2O2-induced cell death in human HepG2 cells assessed as cell viability at 50 uM preincubated for 1 hr followed by H2O2-stimulation and measured after 24 hrs by EZ-Cytox cell viability assay (Rvb = 43.9 +/- 5.25%)2019Journal of natural products, 09-27, Volume: 82, Issue:9
Furanocoumarins from the Roots of
AID1264939Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells assessed as cell viability at 4 to 100 ug/ml pre-incubated for 24 hrs with Abeta ( 1 to 42) followed by compound-Abeta (1 to 42) mixture addition t2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Spiroindole Alkaloids and Spiroditerpenoids from Aspergillus duricaulis and Their Potential Neuroprotective Effects.
AID779150Inhibition of Wnt/beta-catenin signaling pathway in human HEK293 cells at 20 uM after 24 hrs by dual luciferase reporter gene assay relative to vehicle-treated control2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
Anti-proliferative activity of hydnocarpin, a natural lignan, is associated with the suppression of Wnt/β-catenin signaling pathway in colon cancer cells.
AID469919Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 after 48 hrs by broth dilution method2009Journal of natural products, Aug, Volume: 72, Issue:8
Composition of the fresh leaves and stems of Melissa officinalis and evaluation of skin irritation in a reconstituted human epidermis model.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1872430Inhibition of KDM1A (unknown origin) by fluorescence based assay2022European journal of medicinal chemistry, Mar-05, Volume: 231Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).
AID368925Antiviral activity against Japanese encephalitis virus GP78 infected BALB/c mouse assessed as reduction of activated microglia in mouse brain at 25 mg/kg, ip twice daily2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID91425Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Developing a dynamic pharmacophore model for HIV-1 integrase.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1348269Induction of 11.1 mM glucose-stimulated insulin secretion in NMRI mouse pancreatic islets at 10'-6 M after 60 mins by radioimmunoassay relative to control2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID402056Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of unchanged drug level at 200 mg/kg, po after 0 to 48 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1421336Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Rationally designed divalent caffeic amides inhibit amyloid-β fibrillization, induce fibril dissociation, and ameliorate cytotoxicity.
AID469921Antimicrobial activity against Escherichia coli ATCC 8739 after 48 hrs by broth dilution method2009Journal of natural products, Aug, Volume: 72, Issue:8
Composition of the fresh leaves and stems of Melissa officinalis and evaluation of skin irritation in a reconstituted human epidermis model.
AID1395653Cytoprotection against phototoxicity in human NHDF cells assessed as increase in cell viability at 3.9 to 31.3 uM preincubated for 60 mins followed by 150 mJ/cm2 UVB irradiation and measured after 24 hrs by neutral red uptake assay2018European journal of medicinal chemistry, Apr-25, Volume: 150New cytokinin derivatives possess UVA and UVB photoprotective effect on human skin cells and prevent oxidative stress.
AID419924Inhibition of LCK SH2 domain2009Bioorganic & medicinal chemistry letters, Jun-15, Volume: 19, Issue:12
Natural product inhibitors of protein-protein interactions mediated by Src-family SH2 domains.
AID1875585Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in inflammatory cell infiltration in lungs at 4.5 to 18 mg/kg, po for 7 days by H and E staining based microscopic analysis2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID327559Inhibition of HIV1 integrase using labelled U5A/U5B double stranded DNA substrate2008Journal of medicinal chemistry, Apr-24, Volume: 51, Issue:8
Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro- and dinitrorosmarinic acids as new anti-HIV-1 agents.
AID469911Antioxidant activity assessed as DPPH radical scavenging activity2009Journal of natural products, Aug, Volume: 72, Issue:8
Composition of the fresh leaves and stems of Melissa officinalis and evaluation of skin irritation in a reconstituted human epidermis model.
AID265519Inhibition of classical pathway of the complement system2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
Two novel furan derivatives from Phellinus linteus with anti-complement activity.
AID307319Partition coefficient, log P of the compound2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
The structure-activity relationship of the series of non-peptide small antagonists for p56lck SH2 domain.
AID402046Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-m-coumaric acid level at 200 mg/kg, po after 0 to 12 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID402052Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of unchanged drug level at 200 mg/kg, po after 0 to 8 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1887349Cytotoxicity against human WPMY-1 cells assessed as inhibition of cell growth and measured after 72 hrs resazurin reduction assay
AID1374866Reversible inhibition of bacterial N-terminal His6-tagged VIM2 (27 to 266 residues) expressed in Escherichia coli BL21 DE3 pLysS cells at 415 uM using FC-5 as substrate pretreated for 30 mins followed by substrate addition by jump-dilution method2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID1845959Inhibition of LSD1 (unknown origin) by Spectra Max Paradigm Microplate Reader analysis2021European journal of medicinal chemistry, Mar-15, Volume: 214Annual review of LSD1/KDM1A inhibitors in 2020.
AID469913Antimicrobial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by broth dilution method2009Journal of natural products, Aug, Volume: 72, Issue:8
Composition of the fresh leaves and stems of Melissa officinalis and evaluation of skin irritation in a reconstituted human epidermis model.
AID335513ABTS radical scavenging activity assessed as Trolox equivalent antioxidant capacity after 6 mins2002Journal of natural products, Jun, Volume: 65, Issue:6
Isolation and structure elucidation of radical scavengers from Thymus vulgaris leaves.
AID1875581Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in eotaxin level in BALF at 4.5 to 18 mg/kg, po for 7 days by ELISA2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID401778Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of total metabolites at 200 mg/kg, po after 0 to 4 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID368923Antiviral activity against Japanese encephalitis virus GP78 infected BALB/c mouse assessed as reduction in mortality rate at 25 mg/kg, ip twice daily administered 1 day post viral-challenge2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID1698073Neuroprotective activity against glutamate-induced cell death in mouse HT-22 cells assessed as increase in cell viability after 24 hrs by EZ-Cytox assay
AID368930Antiinflammatory activity in Japanese encephalitis virus GP78 infected BALB/c mouse assessed as decrease in virus-induced IFN-gamma levels at 25 mg/kg, ip twice daily after 8 to 9 days relative to control2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID1364656Inhibition of human 17beta-HSD1 expressed in HEK293 cell lysates incubated for 10 mins using [2,4,6,7-3H]-estrone and NADPH by scintillation counting method2017Journal of natural products, 04-28, Volume: 80, Issue:4
Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17β-Hydroxysteroid Dehydrogenase Type 2.
AID1875580Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in OVA specific IgE level in BALF at 4.5 to 9 mg/kg, po for 7 days by ELISA2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID1875582Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in IL-4 cytokine level in BALF at 4.5 to 18 mg/kg, po for 7 days by ELISA2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID1248399Inhibition of alpha-amylase (unknown origin) relative to control2015Bioorganic & medicinal chemistry, Oct-15, Volume: 23, Issue:20
From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.
AID1348274Upregulation of INS2 mRNA expression in NMRI mouse pancreatic islets at 10'-8 M after 72 hrs by Taqman-based qRT-PCR analysis2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID311875Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 24 hrs by broth microdilution assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis.
AID402060Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of total metabolites at 200 mg/kg, po after 0 to 72 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID469912Antimicrobial activity against Staphylococcus aureus ATCC 6538 after 48 hrs by broth dilution method2009Journal of natural products, Aug, Volume: 72, Issue:8
Composition of the fresh leaves and stems of Melissa officinalis and evaluation of skin irritation in a reconstituted human epidermis model.
AID1374868Inhibition of bacterial N-terminal His6-tagged VIM2 (27 to 266 residues) expressed in Escherichia coli BL21 DE3 pLysS cells using FC-5 as substrate in presence of 1 uM zinc by fluorescence assay2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID1348271Induction of 16.7 mM glucose-stimulated insulin secretion in NMRI mouse pancreatic islets at 10'-8 M pretreated for 72 hrs in presence of 11.1 mM glucose followed by 16.7 mM glucose stimulation after 60 mins by radioimmunoassay relative to 16.7 mM glucose2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID471352Inhibition of gelatinolytic activity of MMP2 in rat lung homogenate after 40 mins by SDS-PAGE preincubated for 30 mins2009Journal of natural products, Aug, Volume: 72, Issue:8
Matrix metalloproteinase-2 inhibitors from Clinopodium chinense var. parviflorum.
AID1172639Inhibition of cell proliferation of human U251 cells assessed as cell viability at 100 uM after 72 hrs by sulforhodamine B assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Bioactive triterpenoid saponins and phenolic compounds against glioma cells.
AID420054Inhibition of STAT3 SH2 domain at 200 uM2009Bioorganic & medicinal chemistry letters, Jun-15, Volume: 19, Issue:12
Natural product inhibitors of protein-protein interactions mediated by Src-family SH2 domains.
AID1615750Inhibition of H2O2-induced ROS accumulation in human HepG2 cells at 50 uM assessed as ROS generation preincubated for 1 hr followed by H2O2-stimulation and measured after 30 mins by H2DCFDA staining based flow cytometry (Rvb = 100 +/- 11.53%)2019Journal of natural products, 09-27, Volume: 82, Issue:9
Furanocoumarins from the Roots of
AID1264940Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Spiroindole Alkaloids and Spiroditerpenoids from Aspergillus duricaulis and Their Potential Neuroprotective Effects.
AID1500513Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method2017European journal of medicinal chemistry, Sep-29, Volume: 138Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
AID1862163Inhibition of Mycobacterium tuberculosis UGM expressed in Escherichia coli BL21(DE3) at 500 uM by Fluorescence polarization assay relative to control2022Bioorganic & medicinal chemistry, 09-01, Volume: 69Synthesis and evaluation of inhibitors of Mycobacterium tuberculosis UGM using bioisosteric replacement.
AID401748Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-caffeic acid 4-O-sulfate level at 200 mg/kg, po after 0 to 48 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1348267Induction of 3.3 mM glucose-stimulated insulin secretion in NMRI mouse pancreatic islets at 10'-6 M after 60 mins by radioimmunoassay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID1374878Potentiation of meropenem-induced antimicrobial activity against Escherichia coli BL21(DE3) harboring VIM-2 assessed as meropenem MIC at 25 uM measured after 16 to 20 hrs by microdilution broth method (Rvb = 16 mg/L)2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID401763Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-ferulic acid 4-O-sulfate level at 200 mg/kg, po after 0 to 72 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID420055Inhibition of STAT5b SH2 domain at 200 uM2009Bioorganic & medicinal chemistry letters, Jun-15, Volume: 19, Issue:12
Natural product inhibitors of protein-protein interactions mediated by Src-family SH2 domains.
AID355327Inhibition of HIV reverse transcriptase at 200 ug/ml1997Journal of natural products, Nov, Volume: 60, Issue:11
Saniculoside N from Sanicula europaea L.
AID1875577Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in total IgE level in BALF at 4.5 to 18 mg/kg, po for 7 days by ELISA2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID368931Antiinflammatory activity in Japanese encephalitis virus GP78 infected BALB/c mouse assessed as decrease in virus-induced MCP1 levels at 25 mg/kg, ip twice daily after 8 to 9 days relative to control2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID368936Antiinflammatory activity in Japanese encephalitis virus GP78 infected mouse BV2 cells assessed as decrease in virus-induced IL12 levels at 25 uM after 18 hrs by Western blot relative to control2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID401775Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of m-hydroxyphenyl-propionic acid level at 200 mg/kg, po after 0 to 36 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID469917Antimicrobial activity against Bacillus spizizenii ATCC 6633 after 48 hrs by broth dilution method2009Journal of natural products, Aug, Volume: 72, Issue:8
Composition of the fresh leaves and stems of Melissa officinalis and evaluation of skin irritation in a reconstituted human epidermis model.
AID1169299Competitive binding to TTR V30M mutant (unknown origin) expressed in Escherichia coli at 1 to 80 uM by fluorescence assay2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
AID402055Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of unchanged drug level at 200 mg/kg, po after 0 to 36 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID401766Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-caffeic acid level at 200 mg/kg, po after 0 to 12 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID401760Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-ferulic acid 4-O-sulfate level at 200 mg/kg, po after 0 to 24 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1348277Upregulation of IRS1 mRNA expression in NMRI mouse pancreatic islets at 10'-8 M after 72 hrs by Taqman-based qRT-PCR analysis2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID1348266Induction of 16.7 mM glucose-stimulated insulin secretion in NMRI mouse pancreatic islets at 10'-10 M after 60 mins by radioimmunoassay relative to 16.7 mM glucose control2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID368938Antiinflammatory activity in Japanese encephalitis virus GP78 infected mouse BV2 cells assessed as decrease in virus-induced IFN-gamma levels at 25 uM after 18 hrs by Western blot relative to control2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID538832Inhibition of mushroom tyrosinase at 1.00 mM2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
A novel ring-expanded product with enhanced tyrosinase inhibitory activity from classical Fe-catalyzed oxidation of rosmarinic acid, a potent antioxidative Lamiaceae polyphenol.
AID403342Inhibition of COX1 at 1000 uM2005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID1875584Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in IL-13 cytokine level in BALF at 4.5 to 18 mg/kg, po for 7 days by ELISA2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID1348280Upregulation of GCGR mRNA expression in NMRI mouse pancreatic islets at 10'-8 M after 72 hrs by Taqman-based qRT-PCR analysis2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID401744Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-caffeic acid 4-O-sulfate level at 200 mg/kg, po after 0 to 8 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID469922Antimicrobial activity against Candida albicans ATCC 10231 after 24 hrs by broth dilution method2009Journal of natural products, Aug, Volume: 72, Issue:8
Composition of the fresh leaves and stems of Melissa officinalis and evaluation of skin irritation in a reconstituted human epidermis model.
AID280400Inhibition of human Fyn expressed in Sf9 cells after 20 mins by ELISA in presence of 1 umol/L ATP2007Journal of medicinal chemistry, Mar-22, Volume: 50, Issue:6
Homology modeling of human Fyn kinase structure: discovery of rosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes.
AID469914Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 after 48 hrs by broth dilution method2009Journal of natural products, Aug, Volume: 72, Issue:8
Composition of the fresh leaves and stems of Melissa officinalis and evaluation of skin irritation in a reconstituted human epidermis model.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1374876Potentiation of meropenem-induced antimicrobial activity against Escherichia coli BL21(DE3) assessed as meropenem MIC at 100 uM measured after 16 to 20 hrs by microdilution broth method (Rvb = <0.125 mg/L)2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID1364654Inhibition of human 17beta-HSD2 expressed in HEK293 cell lysates incubated for 10 mins using [2,4,6,7-3H]-estradiol and NAD+ by scintillation counting method2017Journal of natural products, 04-28, Volume: 80, Issue:4
Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17β-Hydroxysteroid Dehydrogenase Type 2.
AID368940Antiinflammatory activity in Japanese encephalitis virus GP78 infected mouse BV2 cells assessed as decrease in virus-induced IL6 levels at 25 uM after 18 hrs by Western blot relative to control2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID1423272Antiproliferative activity against human MOLM14 cells by Cell-Titer Glo assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Salviachinensines A-F, Antiproliferative Phenolic Derivatives from the Chinese Medicinal Plant Salvia chinensis.
AID402048Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-m-coumaric acid level at 200 mg/kg, po after 0 to 36 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1172640Inhibition of cell proliferation of rat C6 cells assessed as cell viability at 100 uM after 72 hrs by sulforhodamine B assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Bioactive triterpenoid saponins and phenolic compounds against glioma cells.
AID357285Inhibition of A23187-induced 15HETE formation in human polymorphonuclear leukocytes at 100 to 1000 uM
AID469915Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 after 24 hrs by broth dilution method2009Journal of natural products, Aug, Volume: 72, Issue:8
Composition of the fresh leaves and stems of Melissa officinalis and evaluation of skin irritation in a reconstituted human epidermis model.
AID477822Inhibition of bovine testis hyaluronidase type 4 after 20 mins by modified Morgan-Elson method2010Journal of natural products, Apr-23, Volume: 73, Issue:4
Hyaluronidase inhibitors from "Cimicifugae Rhizoma" (a mixture of the rhizomes of Cimicifuga dahurica and C. heracleifolia).
AID401773Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of m-hydroxyphenyl-propionic acid level at 200 mg/kg, po after 0 to 12 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID280407Inhibition of human Fyn expressed in Sf9 cells at 30 umol/L by ELISA2007Journal of medicinal chemistry, Mar-22, Volume: 50, Issue:6
Homology modeling of human Fyn kinase structure: discovery of rosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes.
AID401767Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-caffeic acid level at 200 mg/kg, po after 0 to 24 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID332706Inhibition of human plasma alternative complement system assessed as hemolysis of non-sensitized rabbit erythrocytes at 1000 uM1995Journal of natural products, Mar, Volume: 58, Issue:3
In vitro anticomplementary activity of constituents from Morinda morindoides.
AID1374869Inhibition of bacterial N-terminal His6-tagged VIM2 (27 to 266 residues) expressed in Escherichia coli BL21 DE3 pLysS cells using FC-5 as substrate in presence of 1000 uM zinc by fluorescence assay2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID327557Inhibition of HIV1 integrase using labelled oligonucleotide substrate in presence of bovine serum albumin by ELISA2008Journal of medicinal chemistry, Apr-24, Volume: 51, Issue:8
Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro- and dinitrorosmarinic acids as new anti-HIV-1 agents.
AID1500518Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation assessed as lag time of aggregation at 20.3 uM after 24 hrs by inverted fluorescence microscopic method (Rvb = 4.44 hrs)2017European journal of medicinal chemistry, Sep-29, Volume: 138Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
AID1348264Induction of 16.7 mM glucose-stimulated insulin secretion in NMRI mouse pancreatic islets at 10'-6 M after 60 mins by radioimmunoassay relative to 16.7 mM glucose control2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID1875593Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in E-selectin mRNA expression in lungs at 4.5 to 18 mg/kg, po for 7 days by qRT-PCR analysis2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID357284Inhibition of A23187-induced 12-hydroxy-5,8,10-heptadecatrienoic acid formation in human polymorphonuclear leukocytes at 100 to 1000 uM
AID419925Inhibition of c-SRC SH2 domain2009Bioorganic & medicinal chemistry letters, Jun-15, Volume: 19, Issue:12
Natural product inhibitors of protein-protein interactions mediated by Src-family SH2 domains.
AID1374860Inhibition of bacterial N-terminal His6-tagged VIM2 (27 to 266 residues) expressed in Escherichia coli BL21 DE3 pLysS cells using FC-5 as substrate pretreated for 10 mins followed by substrate addition measured every 60 secs by fluorescence assay2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID357272Inhibition of A23187-induced LTB4 formation in human polymorphonuclear leukocytes
AID401774Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of m-hydroxyphenyl-propionic acid level at 200 mg/kg, po after 0 to 24 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID311874Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by broth microdilution assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis.
AID1500516Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation assessed as aggregation growth rate at 20.3 uM after 24 hrs by inverted fluorescence microscopic method (Rvb = 0.533 /hr)2017European journal of medicinal chemistry, Sep-29, Volume: 138Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
AID401092Inhibition of human serum alternative complement system assessed as modulation of complement pathway by alternative hemolytic complement assay1998Journal of natural products, Jun-26, Volume: 61, Issue:6
Complement-inhibiting cucurbitacin glycosides from Picria fel-terrae.
AID401777Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of m-hydroxyphenyl-propionic acid level at 200 mg/kg, po after 0 to 72 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1695730Inhibition of alpha-synuclein fibril formation (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay2019European journal of medicinal chemistry, Apr-01, Volume: 167Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation.
AID402051Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of unchanged drug level at 200 mg/kg, po after 0 to 4 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID469918Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 after 24 hrs by broth dilution method2009Journal of natural products, Aug, Volume: 72, Issue:8
Composition of the fresh leaves and stems of Melissa officinalis and evaluation of skin irritation in a reconstituted human epidermis model.
AID401747Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-caffeic acid 4-O-sulfate level at 200 mg/kg, po after 0 to 36 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID402057Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of unchanged drug level at 200 mg/kg, po after 0 to 72 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID311878Antifungal activity against Candida albicans ATCC 10231 after 24 hrs by broth microdilution assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis.
AID401750Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of total metabolites at 200 mg/kg, po after 0 to 24 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID401757Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-ferulic acid 4-O-sulfate level at 200 mg/kg, po after 0 to 4 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID357269Formation of PGE2 in A-23187-stimulated human polymorphonuclear leukocytes at 10 uM relative to control
AID1374872Inhibition of bacterial N-terminal His6-tagged NDM1 expressed in Escherichia coli BL21 DE3 pLysS cells using FC-5 as substrate pretreated for 10 mins followed by substrate addition measured every 60 secs by fluorescence assay2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID477037Inhibition of aldose reductase2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Evaluation of aldose reductase inhibition and docking studies of 6'-nitro and 6',6''-dinitrorosmarinic acids.
AID357283Enhancement of PGE2 formation in A-23187-stimulated human polymorphonuclear leukocytes at 100 uM
AID1374873Inhibition of bacterial N-terminal His6-tagged TEM1 expressed in Escherichia coli BL21 DE3 pLysS cells using FC-5 as substrate pretreated for 10 mins followed by substrate addition measured every 60 secs by fluorescence assay2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID402058Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of total metabolites at 200 mg/kg, po after 0 to 36 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1374871Binding affinity to bacterial N-terminal His6-tagged VIM2 (27 to 266 residues) expressed in Escherichia coli BL21 DE3 pLysS cells by isothermal calorimetric method2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID1364657Selectivity index, ratio of inhibition of human 17beta-HSD1 expressed in HEK293 cell lysates to inhibition of human 17beta-HSD2 expressed in HEK293 cell lysates2017Journal of natural products, 04-28, Volume: 80, Issue:4
Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17β-Hydroxysteroid Dehydrogenase Type 2.
AID280402Inhibition of human Fyn expressed in Sf9 cells after 20 mins by ELISA in presence of 100 umol/L ATP2007Journal of medicinal chemistry, Mar-22, Volume: 50, Issue:6
Homology modeling of human Fyn kinase structure: discovery of rosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes.
AID311876Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 after 24 hrs by broth microdilution assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis.
AID1348268Induction of 6.6 mM glucose-stimulated insulin secretion in NMRI mouse pancreatic islets at 10'-6 M after 60 mins by radioimmunoassay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID401751Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of total metabolites at 200 mg/kg, po after 0 to 12 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID402049Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-m-coumaric acid level at 200 mg/kg, po after 0 to 48 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID401776Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of m-hydroxyphenyl-propionic acid level at 200 mg/kg, po after 0 to 48 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1348265Induction of 16.7 mM glucose-stimulated insulin secretion in NMRI mouse pancreatic islets at 10'-8 M after 60 mins by radioimmunoassay relative to 16.7 mM glucose control2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID327566Inhibition of HIV1 reverse transcriptase2008Journal of medicinal chemistry, Apr-24, Volume: 51, Issue:8
Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro- and dinitrorosmarinic acids as new anti-HIV-1 agents.
AID1374864Competitive inhibition of bacterial N-terminal His6-tagged VIM2 (27 to 266 residues) expressed in Escherichia coli BL21 DE3 pLysS cells assessed as substrate Km using varying levels of FC-5 as substrate by fluorescence assay2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID327561Inhibition of HIV1 integrase strand transfer activity using labelled oligonucleotide substrate by ELISA2008Journal of medicinal chemistry, Apr-24, Volume: 51, Issue:8
Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro- and dinitrorosmarinic acids as new anti-HIV-1 agents.
AID1862165Inhibition of Mycobacterium tuberculosis UGM expressed in Escherichia coli BL21(DE3) assessed as dissociation constant by fluorescence polarization assay2022Bioorganic & medicinal chemistry, 09-01, Volume: 69Synthesis and evaluation of inhibitors of Mycobacterium tuberculosis UGM using bioisosteric replacement.
AID1374865Competitive inhibition of bacterial N-terminal His6-tagged VIM2 (27 to 266 residues) expressed in Escherichia coli BL21 DE3 pLysS cells assessed as substrate Vmax using varying levels of FC-5 as substrate by fluorescence assay2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID401771Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of total metabolites at 200 mg/kg, po after 0 to 8 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID401091Inhibition of human serum classical complement system assessed as modulation of complement pathway by classical hemolytic complement assay1998Journal of natural products, Jun-26, Volume: 61, Issue:6
Complement-inhibiting cucurbitacin glycosides from Picria fel-terrae.
AID327558Inhibition of HIV1 integrase using labelled oligonucleotide substrate by ELISA2008Journal of medicinal chemistry, Apr-24, Volume: 51, Issue:8
Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro- and dinitrorosmarinic acids as new anti-HIV-1 agents.
AID307316Inhibition of Jurkat cell activation assessed as blocking of T-cell antigen receptor-induced IL-2 expression at 10 uM by luciferase assay2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
The structure-activity relationship of the series of non-peptide small antagonists for p56lck SH2 domain.
AID1395650Cytoprotection against phototoxicity in human HaCaT cells assessed as increase in cell viability at 3.9 uM preincubated for 60 mins followed by 10 J/cm2 UVA irradiation and measured after 24 hrs by neutral red uptake assay2018European journal of medicinal chemistry, Apr-25, Volume: 150New cytokinin derivatives possess UVA and UVB photoprotective effect on human skin cells and prevent oxidative stress.
AID1348276Upregulation of INSR mRNA expression in NMRI mouse pancreatic islets at 10'-8 M after 72 hrs by Taqman-based qRT-PCR analysis2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID380219Modulation of classical complement pathway system assessed as hemoglobin release by spectrophotometry1999Journal of natural products, Jul, Volume: 62, Issue:7
Biological evaluation of proanthocyanidin dimers and related polyphenols.
AID1348184Anti-Trichomonas activity against Trichomonas vaginalis2018European journal of medicinal chemistry, Jan-01, Volume: 143Recent developments in anti-Trichomonas research: An update review.
AID401743Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-caffeic acid 4-O-sulfate level at 200 mg/kg, po after 0 to 4 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1374874Potentiation of meropenem-induced antimicrobial activity against Escherichia coli BL21(DE3) harboring VIM-2 assessed as meropenem MIC at 50 uM measured after 16 to 20 hrs by microdilution broth method (Rvb = 16 mg/L)2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1875583Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in IL-5 cytokine level in BALF at 4.5 to 18 mg/kg, po for 7 days by ELISA2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID327563Antiviral activity against HIV1 3B infected in human MT4 cells assessed as reduction of virus-induced cytopathogenicity by MTT assay2008Journal of medicinal chemistry, Apr-24, Volume: 51, Issue:8
Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro- and dinitrorosmarinic acids as new anti-HIV-1 agents.
AID401768Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-caffeic acid level at 200 mg/kg, po after 0 to 36 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1887347Cytotoxicity against human HeLa cells assessed as inhibition of cell growth and measured after 72 hrs resazurin reduction assay
AID469920Antimicrobial activity against Escherichia coli ATCC 8739 after 24 hrs by broth dilution method2009Journal of natural products, Aug, Volume: 72, Issue:8
Composition of the fresh leaves and stems of Melissa officinalis and evaluation of skin irritation in a reconstituted human epidermis model.
AID368932Antiinflammatory activity in Japanese encephalitis virus GP78 infected BALB/c mouse assessed as decrease in virus-induced IL6 levels at 25 mg/kg, ip twice daily after 8 to 9 days relative to control2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID402059Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of total metabolites at 200 mg/kg, po after 0 to 48 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1348279Upregulation of MFAB mRNA expression in NMRI mouse pancreatic islets at 10'-8 M after 72 hrs by Taqman-based qRT-PCR analysis2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID335511Antioxidant activity assessed as DPPH radical scavenging activity after 1 min2002Journal of natural products, Jun, Volume: 65, Issue:6
Isolation and structure elucidation of radical scavengers from Thymus vulgaris leaves.
AID1395648Cytoprotection against phototoxicity in human HaCaT cells assessed as increase in cell viability at 3.9 to 31.3 uM preincubated for 60 mins followed by 10 J/cm2 UVA irradiation and measured after 24 hrs by neutral red uptake assay2018European journal of medicinal chemistry, Apr-25, Volume: 150New cytokinin derivatives possess UVA and UVB photoprotective effect on human skin cells and prevent oxidative stress.
AID538830Inhibition of mushroom tyrosinase at 10.0 mM2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
A novel ring-expanded product with enhanced tyrosinase inhibitory activity from classical Fe-catalyzed oxidation of rosmarinic acid, a potent antioxidative Lamiaceae polyphenol.
AID592088Antihemorrhagic activity in ddY mouse assessed as inhibition of Protobothrops flavoviridis venom-induced hemorrhage incubated with compound for 10 mins measured after 24 hrs2011Bioorganic & medicinal chemistry, Apr-01, Volume: 19, Issue:7
Contribution of cinnamic acid analogues in rosmarinic acid to inhibition of snake venom induced hemorrhage.
AID401754Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-m-coumaric acid 3-O-sulfate level at 200 mg/kg, po after 0 to 36 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1875576Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in OVA specific IgE level in serum at 4.5 to 18 mg/kg, po for 7 days by ELISA2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID1500524Antioxidant activity assessed as inhibition of DPPH radical at 500 uM incubated for 20 mins measured for 60 mins relative to control2017European journal of medicinal chemistry, Sep-29, Volume: 138Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
AID401756Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-m-coumaric acid 3-O-sulfate level at 200 mg/kg, po after 0 to 72 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID368935Antiinflammatory activity in Japanese encephalitis virus GP78 infected BALB/c mouse assessed as decrease in Cox2 levels at 25 mg/kg, ip twice daily after 8 to 9 days relative to control2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID1617647Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as decrease in PGE2 production preincubated for 1 hr followed by LPS stimulation and measured after 24 hrs by ELISA
AID335509Antioxidant activity assessed as DPPH radical scavenging activity at drug-DPPH molar ratio of 1:2 after 15 mins2002Journal of natural products, Jun, Volume: 65, Issue:6
Isolation and structure elucidation of radical scavengers from Thymus vulgaris leaves.
AID401761Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-ferulic acid 4-O-sulfate level at 200 mg/kg, po after 0 to 36 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1862164Inhibition of Klebsiella pneumoniae UGM expressed in Escherichia coli BL21(DE3) assessed as dissociation constant by fluorescence polarization assay2022Bioorganic & medicinal chemistry, 09-01, Volume: 69Synthesis and evaluation of inhibitors of Mycobacterium tuberculosis UGM using bioisosteric replacement.
AID734065Inhibition of human recombinant MMP1 catalytic domain using Dnp-Pro-beta-cyclohexyl-Ala-Gly-Cys(Me)-His-Lys-(Nma)-NH2 as substrate at 10 uM preincubated with enzyme for 30 mins prior to substrate addition measured after 20 mins by fluorometric assay2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1).
AID402050Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-m-coumaric acid level at 200 mg/kg, po after 0 to 72 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID311873Antioxidant activity assessed as DPPH reducing activity2007Journal of natural products, Dec, Volume: 70, Issue:12
Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis.
AID357275Inhibition of A23187-induced 15HETE formation in human polymorphonuclear leukocytes
AID1348275Upregulation of PDX1 mRNA expression in NMRI mouse pancreatic islets at 10'-8 M after 72 hrs by Taqman-based qRT-PCR analysis2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID1348278Upregulation of GLUT2 mRNA expression in NMRI mouse pancreatic islets at 10'-8 M after 72 hrs by Taqman-based qRT-PCR analysis2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID368939Antiinflammatory activity in Japanese encephalitis virus GP78 infected mouse BV2 cells assessed as decrease in virus-induced MCP1 levels at 25 uM after 18 hrs by Western blot relative to control2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID1875579Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in OVA specific IgE level in serum at 4.5 to 9 mg/kg, po for 7 days by ELISA2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID419928Inhibition of STAT1 SH2 domain at 200 uM2009Bioorganic & medicinal chemistry letters, Jun-15, Volume: 19, Issue:12
Natural product inhibitors of protein-protein interactions mediated by Src-family SH2 domains.
AID332704Inhibition of guinea pig classical complement system assessed as hemolysis of sensitized sheep erythrocytes at 1000 uM1995Journal of natural products, Mar, Volume: 58, Issue:3
In vitro anticomplementary activity of constituents from Morinda morindoides.
AID538831Inhibition of mushroom tyrosinase at 3.00 mM2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
A novel ring-expanded product with enhanced tyrosinase inhibitory activity from classical Fe-catalyzed oxidation of rosmarinic acid, a potent antioxidative Lamiaceae polyphenol.
AID280406Inhibition of human Fyn expressed in Sf9 cells at 10 umol/L by ELISA2007Journal of medicinal chemistry, Mar-22, Volume: 50, Issue:6
Homology modeling of human Fyn kinase structure: discovery of rosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes.
AID311877Antibacterial activity against Escherichia coli ATCC 8739 after 24 hrs by broth microdilution assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis.
AID1348270Induction of 16.7 mM glucose-stimulated insulin secretion in NMRI mouse pancreatic islets at 10'-6 M after 60 mins by radioimmunoassay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID475505Binding affinity to amyloid beta (1 to 42) oligomers by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID401762Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-ferulic acid 4-O-sulfate level at 200 mg/kg, po after 0 to 48 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID280401Inhibition of human Fyn expressed in Sf9 cells after 20 mins by ELISA in presence of 10 umol/L ATP2007Journal of medicinal chemistry, Mar-22, Volume: 50, Issue:6
Homology modeling of human Fyn kinase structure: discovery of rosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes.
AID1374870Binding affinity to bacterial N-terminal His6-tagged VIM2 (27 to 266 residues) expressed in Escherichia coli BL21 DE3 pLysS cells assessed as dissociation constant by isothermal calorimetric method2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID368927Antiviral activity against Japanese encephalitis virus GP78 infected BALB/c mouse assessed as inhibition of viral mRNA transcript in mouse brain at 25 mg/kg, ip twice daily after 8 to 9 days2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID1484011Inhibition of amyloid beta (1 to 42) aggregation in Escherichia coli competent cells BL21 (DE3) at 200 uM after overnight incubation by Thioflavin-S steady-state fluorescence assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
AID730190Antiviral activity against Respiratory syncytial virus assessed as reduction of virus-induced cytopathic effect at maximal non-toxic concentration2013Bioorganic & medicinal chemistry letters, Mar-01, Volume: 23, Issue:5
Five new phenolic glycosides from Hedyotis scandens.
AID1420937Antioxidant activity assessed as DPPH free radical scavenging activity incubated for 30 min by UV-vis spectrophotometric analysis2018European journal of medicinal chemistry, Oct-05, Volume: 158Antibacterial and antioxidant activities for natural and synthetic dual-active compounds.
AID1067094Inhibition of transcription factor AP-1 binding to oligonucleotide containing TPA-responsive element in TPA-activated human HeLa cells after 1 hr by ELISA2014Bioorganic & medicinal chemistry, Mar-01, Volume: 22, Issue:5
Chemical constituents of Plectranthus amboinicus and the synthetic analogs possessing anti-inflammatory activity.
AID377071Antioxidant activity assessed as DPPH radical scavenging activity studied at DPPH to compound ratio of 22005Journal of natural products, Feb, Volume: 68, Issue:2
Identification of radical scavenging compounds in Rhaponticum carthamoides by means of LC-DAD-SPE-NMR.
AID368926Antiviral activity against Japanese encephalitis virus GP78 infected BALB/c mouse assessed as inhibition of viral proteins in mouse brain at 25 mg/kg, ip twice daily after 8 to 9 days by immunoblot2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID1875575Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in total IgE level in serum at 4.5 to 18 mg/kg, po for 7 days by ELISA2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID357267Formation of PGE2 in A-23187-stimulated human polymorphonuclear leukocytes at 1000 uM relative to control
AID311880Antibacterial activity against Bacillus subtilis subsp. spizizenii ATCC 9027 after 24 hrs by broth microdilution assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis.
AID477408Inhibition of hyaluronidase2010Journal of natural products, Apr-23, Volume: 73, Issue:4
Phenolic constituents of the aerial parts of Cimicifuga simplex and Cimicifuga japonica.
AID401752Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-m-coumaric acid 3-O-sulfate level at 200 mg/kg, po after 0 to 12 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID469926Antimicrobial activity against Aspergillus niger ATCC 16404 after 5 days by broth dilution method2009Journal of natural products, Aug, Volume: 72, Issue:8
Composition of the fresh leaves and stems of Melissa officinalis and evaluation of skin irritation in a reconstituted human epidermis model.
AID368928Antiinflammatory activity in Japanese encephalitis virus GP78 infected BALB/c mouse assessed as decrease in virus-induced IL12 levels at 25 mg/kg, ip twice daily after 8 to 9 days relative to control2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID1875587Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in NFkappaB protein expression in lungs at 4.5 to 18 mg/kg, po for 7 days by immunohistochemistry analysis2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID401755Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-m-coumaric acid 3-O-sulfate level at 200 mg/kg, po after 0 to 48 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID469923Antimicrobial activity against Candida albicans ATCC 10231 after 5 days by broth dilution method2009Journal of natural products, Aug, Volume: 72, Issue:8
Composition of the fresh leaves and stems of Melissa officinalis and evaluation of skin irritation in a reconstituted human epidermis model.
AID357273Inhibition of A23187-induced 12-hydroxy-5,8,10-heptadecatrienoic acid formation in human polymorphonuclear leukocytes
AID401759Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-ferulic acid 4-O-sulfate level at 200 mg/kg, po after 0 to 12 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1875590Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in CCL11 mRNA expression in lungs at 4.5 to 18 mg/kg, po for 7 days by qRT-PCR analysis2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID1374881Potentiation of meropenem-induced antimicrobial activity against Escherichia coli BL21(DE3) assessed as meropenem MIC at 10 uM measured after 16 to 20 hrs by microdilution broth method (Rvb = <0.125 mg/L)2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID327564Cytotoxicity against human MT4 cells by MTT method2008Journal of medicinal chemistry, Apr-24, Volume: 51, Issue:8
Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro- and dinitrorosmarinic acids as new anti-HIV-1 agents.
AID401772Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of m-hydroxyphenyl-propionic acid level at 200 mg/kg, po after 0 to 8 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1875592Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in YM2 mRNA expression in lungs at 4.5 to 18 mg/kg, po for 7 days by qRT-PCR analysis2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID1862162Inhibition of Klebsiella pneumoniae UGM expressed in Escherichia coli BL21(DE3) at 500 uM by Fluorescence polarization assay relative to control2022Bioorganic & medicinal chemistry, 09-01, Volume: 69Synthesis and evaluation of inhibitors of Mycobacterium tuberculosis UGM using bioisosteric replacement.
AID357274Inhibition of A23187-induced 5HETE formation in human polymorphonuclear leukocytes
AID368937Antiinflammatory activity in Japanese encephalitis virus GP78 infected mouse BV2 cells assessed as decrease in virus-induced TNFalpha levels at 25 uM after 18 hrs by Western blot relative to control2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID380220Modulation of alternative complement pathway system assessed as hemoglobin release by spectrophotometry1999Journal of natural products, Jul, Volume: 62, Issue:7
Biological evaluation of proanthocyanidin dimers and related polyphenols.
AID401764Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-caffeic acid level at 200 mg/kg, po after 0 to 4 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1875589Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in AMCase mRNA expression in lungs at 4.5 to 18 mg/kg, po for 7 days by qRT-PCR analysis2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID401753Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-m-coumaric acid 3-O-sulfate level at 200 mg/kg, po after 0 to 24 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1423271Antiproliferative activity against human MOLM13 cells by Cell-Titer Glo assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Salviachinensines A-F, Antiproliferative Phenolic Derivatives from the Chinese Medicinal Plant Salvia chinensis.
AID1423273Antiproliferative activity against human MV4-11 cells by Cell-Titer Glo assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Salviachinensines A-F, Antiproliferative Phenolic Derivatives from the Chinese Medicinal Plant Salvia chinensis.
AID280405Inhibition of human Fyn expressed in Sf9 cells after 1 min by ELISA in presence of 100 umol/L ATP2007Journal of medicinal chemistry, Mar-22, Volume: 50, Issue:6
Homology modeling of human Fyn kinase structure: discovery of rosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes.
AID1264938Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells preincubated for 1 hr followed by amyloid beta challenge measured after 24 hrs by MTT assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Spiroindole Alkaloids and Spiroditerpenoids from Aspergillus duricaulis and Their Potential Neuroprotective Effects.
AID401745Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-caffeic acid 4-O-sulfate level at 200 mg/kg, po after 0 to 12 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1500514Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation assessed as change in fluorescence at 20.3 uM after 24 hrs by inverted fluorescence microscopic method (Rvb = 6.77 No_unit)2017European journal of medicinal chemistry, Sep-29, Volume: 138Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
AID1875591Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in CCR3 mRNA expression in lungs at 4.5 to 18 mg/kg, po for 7 days by qRT-PCR analysis2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID402054Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of unchanged drug level at 200 mg/kg, po after 0 to 24 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1875586Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in airway epithelial thickening in lungs at 4.5 to 18 mg/kg, po for 7 days by H and E staining based microscopic analysis2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID1395647Cytoprotection against phototoxicity in human NHDF cells assessed as increase in cell viability at 3.9 to 31.3 uM preincubated for 60 mins followed by 7.5 J/cm2 UVA irradiation and measured after 24 hrs by neutral red uptake assay2018European journal of medicinal chemistry, Apr-25, Volume: 150New cytokinin derivatives possess UVA and UVB photoprotective effect on human skin cells and prevent oxidative stress.
AID332708Inhibition of guinea pig classical complement system assessed as hemolysis of sensitized sheep erythrocytes1995Journal of natural products, Mar, Volume: 58, Issue:3
In vitro anticomplementary activity of constituents from Morinda morindoides.
AID1625135Antioxidant activity assessed as trolox equivalents of AAPH radical scavenging activity at 50 uM preincubated for 10 mins followed by AAPH addition and measured every min for 30 mins by ORAC-FL assay2019Journal of natural products, 03-22, Volume: 82, Issue:3
Synthesis of Rosmarinic Acid Amides as Antioxidative and Hypoglycemic Agents.
AID307317Inhibition of Jurkat cell activation assessed as blocking of T-cell antigen receptor-induced IL-2 expression at 30 uM by luciferase assay2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
The structure-activity relationship of the series of non-peptide small antagonists for p56lck SH2 domain.
AID402045Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-m-coumaric acid level at 200 mg/kg, po after 0 to 8 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID475504Binding affinity to amyloid beta (1 to 42) fibrils by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID1374879Potentiation of meropenem-induced antimicrobial activity against Escherichia coli BL21(DE3) assessed as meropenem MIC at 25 uM measured after 16 to 20 hrs by microdilution broth method (Rvb = <0.125 mg/L)2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID401746Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-caffeic acid 4-O-sulfate level at 200 mg/kg, po after 0 to 24 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID402047Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-m-coumaric acid level at 200 mg/kg, po after 0 to 24 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID93530Inhibition of strand transfer activity of HIV-1 integrase1997Journal of medicinal chemistry, Sep-12, Volume: 40, Issue:19
Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action.
AID1348273Upregulation of INS1 mRNA expression in NMRI mouse pancreatic islets at 10'-8 M after 72 hrs by Taqman-based qRT-PCR analysis2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID397586Effect on human plasma LDL-PLA2 activity by LS-3B fluorescence spectrometry2001Journal of natural products, Apr, Volume: 64, Issue:4
Specific antioxidant activity of caffeoyl derivatives and other natural phenolic compounds: LDL protection against oxidation and decrease in the proinflammatory lysophosphatidylcholine production.
AID1169291Inhibition of TTR V30M mutant (unknown origin) expressed in Escherichia coli assessed as inhibition of amyloid fibril formation by fluorescence assay2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
AID1500523Antioxidant activity assessed as inhibition of DPPH radical at 100 uM incubated for 20 mins measured for 60 mins relative to control2017European journal of medicinal chemistry, Sep-29, Volume: 138Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
AID401765Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-caffeic acid level at 200 mg/kg, po after 0 to 8 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID280404Inhibition of human Fyn expressed in Sf9 cells after 1 min by ELISA in presence of 10 umol/L ATP2007Journal of medicinal chemistry, Mar-22, Volume: 50, Issue:6
Homology modeling of human Fyn kinase structure: discovery of rosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes.
AID368924Toxicity in BALB/c mouse assessed as behavioral activity at 25 mg/kg, ip twice daily2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID1887348Cytotoxicity against human SH-SY5Y cells assessed as inhibition of cell growth and measured after 72 hrs resazurin reduction assay
AID598309Inhibition of TNF-alpha-induced NF-kappaB transactivation expressed in human HepG2 cells at 20 uM preincubated 1 hr before TNFalpha challenge measured after 1 hr by luciferase reporter gene assay2011Bioorganic & medicinal chemistry letters, Jun-01, Volume: 21, Issue:11
Anti-inflammatory activity of constituents from Glechoma hederacea var. longituba.
AID1500522Inhibition of butter milk XOD (unknown origin) at 100 uM using xanthine as substrate after 8 mins relative to control2017European journal of medicinal chemistry, Sep-29, Volume: 138Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
AID469925Antimicrobial activity against Aspergillus niger ATCC 16404 after 24 hrs by broth dilution method2009Journal of natural products, Aug, Volume: 72, Issue:8
Composition of the fresh leaves and stems of Melissa officinalis and evaluation of skin irritation in a reconstituted human epidermis model.
AID397153Antioxidant activity against Cu2+-induced lipid peroxidation in human plasma LDL preincubated for 1 hr before Cu2+ challenge2001Journal of natural products, Apr, Volume: 64, Issue:4
Specific antioxidant activity of caffeoyl derivatives and other natural phenolic compounds: LDL protection against oxidation and decrease in the proinflammatory lysophosphatidylcholine production.
AID538837Inhibition of mushroom tyrosinase2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
A novel ring-expanded product with enhanced tyrosinase inhibitory activity from classical Fe-catalyzed oxidation of rosmarinic acid, a potent antioxidative Lamiaceae polyphenol.
AID401769Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-caffeic acid level at 200 mg/kg, po after 0 to 48 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID307315Inhibition of p56lck SH2 domain by ELISA2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
The structure-activity relationship of the series of non-peptide small antagonists for p56lck SH2 domain.
AID1374875Potentiation of meropenem-induced antimicrobial activity against Escherichia coli BL21(DE3) harboring VIM-2 assessed as meropenem MIC at 100 uM measured after 16 to 20 hrs by microdilution broth method (Rvb = 16 mg/L)2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID1395657Antioxidant activity assessed as trolox equivalent of AAPH-induced radical scavenging activity at 1 uM pretreated for 15 mins followed by APPH challenge measured every 3 mins over 90 mins by ORAC-FL assay2018European journal of medicinal chemistry, Apr-25, Volume: 150New cytokinin derivatives possess UVA and UVB photoprotective effect on human skin cells and prevent oxidative stress.
AID707987Inhibition of HIV1 His6-tagged integrase-human GST tagged LEDGF/p75 (373-442 residues) interaction after 30 mins by AlphaScreen assay2012Journal of medicinal chemistry, Nov-26, Volume: 55, Issue:22
Discovery of inhibitors to block interactions of HIV-1 integrase with human LEDGF/p75 via structure-based virtual screening and bioassays.
AID469916Antimicrobial activity against Bacillus spizizenii ATCC 6633 after 24 hrs by broth dilution method2009Journal of natural products, Aug, Volume: 72, Issue:8
Composition of the fresh leaves and stems of Melissa officinalis and evaluation of skin irritation in a reconstituted human epidermis model.
AID1625134Antioxidant activity assessed as DPPH radical scavenging activity incubated for 1.5 hrs under dark condition by spectrometric method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Synthesis of Rosmarinic Acid Amides as Antioxidative and Hypoglycemic Agents.
AID401758Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-ferulic acid 4-O-sulfate level at 200 mg/kg, po after 0 to 8 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID402053Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of unchanged drug level at 200 mg/kg, po after 0 to 12 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID1625133Inhibition of yeast alpha-glucosidase using pNP-alpha-G as substrate measured after 30 mins2019Journal of natural products, 03-22, Volume: 82, Issue:3
Synthesis of Rosmarinic Acid Amides as Antioxidative and Hypoglycemic Agents.
AID368933Antiinflammatory activity in Japanese encephalitis virus GP78 infected BALB/c mouse assessed as increase in IkappaB-alpha levels at 25 mg/kg, ip twice daily after 8 to 9 days relative to control2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID1500521Inhibition of butter milk XOD (unknown origin) at 10 uM using xanthine as substrate after 8 mins relative to control2017European journal of medicinal chemistry, Sep-29, Volume: 138Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
AID368934Antiinflammatory activity in Japanese encephalitis virus GP78 infected BALB/c mouse assessed as decrease in phosphorylated NF-kappaB levels at 25 mg/kg, ip twice daily after 8 to 9 days relative to control2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID1875588Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in NFkappaB protein expression in lungs at 4.5 to 18 mg/kg, po for 7 days by western blot analysis2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID334590Antioxidant activity against Cu2+-induced lipid peroxidation in human plasma LDL preincubated for 1 hr before Cu2+ challenge relative to probucol2002Journal of natural products, May, Volume: 65, Issue:5
Anti-lipid-peroxidative principles from Tournefortia sarmentosa.
AID598307Cytotoxicity against human HepG2 cells up to 20 uM after 24 hrs by MTS assay2011Bioorganic & medicinal chemistry letters, Jun-01, Volume: 21, Issue:11
Anti-inflammatory activity of constituents from Glechoma hederacea var. longituba.
AID1374880Potentiation of meropenem-induced antimicrobial activity against Escherichia coli BL21(DE3) harboring VIM-2 assessed as meropenem MIC at 10 uM measured after 16 to 20 hrs by microdilution broth method (Rvb = 16 mg/L)2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases.
AID368929Antiinflammatory activity in Japanese encephalitis virus GP78 infected BALB/c mouse assessed as decrease in virus-induced TNFalpha levels at 25 mg/kg, ip twice daily after 8 to 9 days relative to control2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.
AID334589Antioxidant activity against Cu2+-induced lipid peroxidation in human plasma LDL preincubated for 1 hr before Cu2+ challenge2002Journal of natural products, May, Volume: 65, Issue:5
Anti-lipid-peroxidative principles from Tournefortia sarmentosa.
AID280403Inhibition of human Fyn expressed in Sf9 cells after 1 min by ELISA in presence of 1 umol/L ATP2007Journal of medicinal chemistry, Mar-22, Volume: 50, Issue:6
Homology modeling of human Fyn kinase structure: discovery of rosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes.
AID356578Inhibition of human serum complement system-mediated hemolysis2003Journal of natural products, Oct, Volume: 66, Issue:10
Lactones from the leaves of Litsea japonica and their anti-complement activity.
AID311879Antifungal activity against Aspergillus niger ATCC 16404 after 24 hrs by broth microdilution assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis.
AID1875578Anti-asthmatic activity against ovalbumin-induced asthmatic Sprague-Dawley rat model assessed as reduction in OVA specific IgE level in BALF at 4.5 to 18 mg/kg, po for 7 days by ELISA2022Journal of natural products, 11-25, Volume: 85, Issue:11
Antiasthmatic Compounds Targeting β
AID1348272Induction of 3.3 mM glucose-stimulated insulin secretion in NMRI mouse pancreatic islets at 10'-8 M pretreated for 72 hrs in presence of 11.1 mM glucose followed by 3.3 mM glucose stimulation after 60 mins by radioimmunoassay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Phenolic Substances from Ocimum Species Enhance Glucose-Stimulated Insulin Secretion and Modulate the Expression of Key Insulin Regulatory Genes in Mice Pancreatic Islets.
AID401770Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-caffeic acid level at 200 mg/kg, po after 0 to 72 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID377070Antioxidant activity assessed as DPPH radical scavenging activity studied at DPPH to compound ratio of 52005Journal of natural products, Feb, Volume: 68, Issue:2
Identification of radical scavenging compounds in Rhaponticum carthamoides by means of LC-DAD-SPE-NMR.
AID327560Inhibition of HIV1 integrase 3'-processing activity using labelled oligonucleotide substrate by ELISA2008Journal of medicinal chemistry, Apr-24, Volume: 51, Issue:8
Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro- and dinitrorosmarinic acids as new anti-HIV-1 agents.
AID1887346Cytotoxicity against human PC-3 cells assessed as inhibition of cell growth and measured after 72 hrs resazurin reduction assay
AID357288Cytotoxicity against human polymorphonuclear leukocytes assessed as occurrence of cell suspension or lactate dehydrogenase release at 1 to 1000 uM
AID224158Inhibition of binding to p56 Lck tyrosine kinase SH2 domain2003Bioorganic & medicinal chemistry letters, Oct-20, Volume: 13, Issue:20
Design and synthesis of small chemical inhibitors containing different scaffolds for lck SH2 domain.
AID1420936Antibacterial activity against Escherichia coli K-12 MG1655 assessed as bacterial growth inhibition after 24 hrs by serial dilutoin method2018European journal of medicinal chemistry, Oct-05, Volume: 158Antibacterial and antioxidant activities for natural and synthetic dual-active compounds.
AID734064Inhibition of human recombinant MMP1 catalytic domain using Dnp-Pro-beta-cyclohexyl-Ala-Gly-Cys(Me)-His-Lys-(Nma)-NH2 as substrate preincubated with enzyme for 30 mins prior to substrate addition measured after 20 mins by fluorometric assay2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1).
AID93515Inhibition of 3'- processing activity of HIV-1 integrase1997Journal of medicinal chemistry, Sep-12, Volume: 40, Issue:19
Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action.
AID335512ABTS radical scavenging activity assessed as Trolox equivalent antioxidant capacity after 1 min2002Journal of natural products, Jun, Volume: 65, Issue:6
Isolation and structure elucidation of radical scavengers from Thymus vulgaris leaves.
AID401749Metabolic stability in Sprague-Dawley rat assessed as urinary excretion of trans-caffeic acid 4-O-sulfate level at 200 mg/kg, po after 0 to 72 hrs by HPLC1998Journal of natural products, Aug, Volume: 61, Issue:8
Metabolism of rosmarinic acid in rats.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1799684Inhibition Assay from Article 10.1080/14756360600991017: \\Inhibitory effect on soybean lipoxygenase and docking studies of some secondary metabolites, isolated from Origanum vulgare L. ssp. hirtum.\\2007Journal of enzyme inhibition and medicinal chemistry, Feb, Volume: 22, Issue:1
Inhibitory effect on soybean lipoxygenase and docking studies of some secondary metabolites, isolated from Origanum vulgare L. ssp. hirtum.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,151)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (1.04)18.7374
1990's23 (2.00)18.2507
2000's183 (15.90)29.6817
2010's625 (54.30)24.3611
2020's308 (26.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.62 (24.57)
Research Supply Index7.08 (2.92)
Research Growth Index5.60 (4.65)
Search Engine Demand Index103.99 (26.88)
Search Engine Supply Index3.98 (0.95)

This Compound (35.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials15 (1.28%)5.53%
Reviews0 (0.00%)6.00%
Reviews48 (4.09%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational1 (0.09%)0.25%
Other10 (100.00%)84.16%
Other1,110 (94.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Human Clinical Trial to Investigate the Effects of High Rosmarinic Acid Spearmint Tea on Markers of Pain, Physical Function and Disease Activity in Osteoarthritis of the Knee [NCT01380015]Phase 449 participants (Actual)Interventional2011-07-31Completed
A Double-blind,Placebo-controlled, Randomized, Crossover Trial of Mint Tea High in Rosmarinic Acid in Adults With Nasal Polyposis [NCT00465543]Phase 222 participants (Actual)Interventional2007-05-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]